<SEC-DOCUMENT>0001104659-22-045016.txt : 20220412
<SEC-HEADER>0001104659-22-045016.hdr.sgml : 20220412
<ACCEPTANCE-DATETIME>20220412144729
ACCESSION NUMBER:		0001104659-22-045016
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20220609
FILED AS OF DATE:		20220412
DATE AS OF CHANGE:		20220412

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEKLA HEALTHCARE INVESTORS
		CENTRAL INDEX KEY:			0000805267
		IRS NUMBER:				046564285
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	811-04889
		FILM NUMBER:		22821947

	BUSINESS ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		6177728515

	MAIL ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	H&Q HEALTHCARE INVESTORS
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tekla World Healthcare Fund
		CENTRAL INDEX KEY:			0001635977
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			MA

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	811-23037
		FILM NUMBER:		22821948

	BUSINESS ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		(617) 772-8515

	MAIL ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tekla Healthcare Opportunities Fund
		CENTRAL INDEX KEY:			0001604522
		IRS NUMBER:				465317248
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	811-22955
		FILM NUMBER:		22821949

	BUSINESS ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		617-772-8500

	MAIL ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tekla Healthcare Growth & Income Fund
		DATE OF NAME CHANGE:	20140402
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>tm222535d1_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<html><head><meta content="text/html; charset=ASCII">
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#xa0;</p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#xa0;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#xa0;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif"><b>UNITED
STATES</b></font></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif"><b></b></font><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SCHEDULE 14A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proxy Statement Pursuant to Section&#xa0;14(a)&#xa0;of<br>
the Securities Exchange Act of 1934 (Amendment No.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="4" style="padding-right: 0.7pt; padding-left: 0.7pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by the Registrant&#xa0;&#xa0;</font><font>&#x2612;</font></td></tr>
  <tr style="vertical-align: top">
    <td colspan="4" style="padding-right: 0.7pt; padding-left: 0.7pt">&#xa0;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="4" style="padding-right: 0.7pt; padding-left: 0.7pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by a Party other than the Registrant</font>&#xa0;&#xa0;<font>&#x2610;</font></td></tr>
  <tr style="vertical-align: top">
    <td colspan="4" style="padding-right: 0.7pt; padding-left: 0.7pt">&#xa0;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="4" style="padding-right: 0.7pt; padding-left: 0.7pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check the appropriate box:</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.7pt; padding-left: 0.7pt"><font>&#x2610;</font></td>
    <td colspan="1" style="padding-right: 0.7pt; padding-left: 0.7pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary Proxy Statement</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.7pt; padding-left: 0.7pt"><font style=" font-size: 10pt"><font>&#x2610;</font></font></td>
    <td colspan="1" style="padding-right: 0.7pt; padding-left: 0.7pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Confidential, for Use of the Commission Only (as permitted by Rule&#xa0;14a-6(e)(2))</b></font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.7pt; padding-left: 0.7pt"><font style=" font-size: 10pt"><font>&#x2612;</font></font></td>
    <td colspan="1" style="padding-right: 0.7pt; padding-left: 0.7pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Proxy Statement</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.7pt; padding-left: 0.7pt"><font style=" font-size: 10pt"><font>&#x2610;</font></font></td>
    <td colspan="1" style="padding-right: 0.7pt; padding-left: 0.7pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Additional Materials</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.7pt; padding-left: 0.7pt"><font style=" font-size: 10pt"><font>&#x2610;</font></font></td>
    <td colspan="1" style="padding-right: 0.7pt; padding-left: 0.7pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting Material under &#xa7;240.14a-12</font></td></tr>
  <tr style="vertical-align: top">
    <td colspan="4" style="padding-right: 0.7pt; padding-left: 0.7pt; text-align: center">&#xa0;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="4" style="border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>Tekla Healthcare Investors, Tekla Heathcare Opportunities Fund, Tekla World <br>
Healthcare Fund</b></font></td></tr>
  <tr style="vertical-align: top">
    <td colspan="4" style="padding-right: 0.7pt; padding-left: 0.7pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name of Registrant as Specified In Its Charter)</font></td></tr>
  <tr style="vertical-align: top">
    <td colspan="4" style="padding-right: 0.7pt; padding-left: 0.7pt; text-align: center">&#xa0;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="4" style="border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt; text-align: center">&#xa0;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="4" style="padding-right: 0.7pt; padding-left: 0.7pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name of Person(s)&#xa0;Filing Proxy Statement, if other than the Registrant)</font></td></tr>
  <tr style="vertical-align: top">
    <td colspan="4" style="padding-right: 0.7pt; padding-left: 0.7pt">&#xa0;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="4" style="padding-right: 0.7pt; padding-left: 0.7pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment of Filing Fee (Check the appropriate box):</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.7pt; padding-left: 0.7pt"><font style=" font-size: 10pt"><font>&#x2612;</font></font></td>
    <td colspan="1" style="padding-right: 0.7pt; padding-left: 0.7pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No fee required.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.7pt; padding-left: 0.7pt"><font>&#x2610;</font></td>
    <td colspan="1" style="padding-right: 0.7pt; padding-left: 0.7pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee paid previously with preliminary materials.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.7pt; padding-left: 0.7pt"><font>&#x2610;</font></td>
    <td colspan="1" style="padding-right: 0.7pt; padding-left: 0.7pt">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#xa0;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#xa0;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#xa0;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 50%">&#xa0;</td><td style="width: 50%; text-align: right">&#xa0;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->


<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><b>TEKLA HEALTHCARE INVESTORS<br>TEKLA HEALTHCARE OPPORTUNITIES FUND<br>TEKLA WORLD HEALTHCARE FUND<br></b>100 Federal Street, 19th Floor<br>Boston, Massachusetts 02110<br>(617) 772-8500</p>
<p style="margin:24pt 0pt 18pt 0pt; text-align: center;"><b>NOTICE OF JOINT ANNUAL MEETING OF SHAREHOLDERS</b></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;">To the Shareholders of TEKLA HEALTHCARE INVESTORS, TEKLA HEALTHCARE OPPORTUNITIES FUND AND TEKLA WORLD HEALTHCARE FUND:</p>
<p style="margin:6pt 0pt 0pt 0pt;">An Annual Meeting of Shareholders of Tekla Healthcare Investors ("HQH"), Tekla Healthcare Opportunities Fund ("THQ") and Tekla World Healthcare Fund ("THW") (each a "Fund", together the "Funds") will be held on Thursday, June 9, 2022 at 4:30 p.m. at 100 Federal Street, 19th Floor, Boston, Massachusetts 02110, for the following purposes:</p>
<p style="margin:6pt 0pt 0pt 0pt;">(1)&#xa0;&#xa0;The election of Trustees of each Fund;</p>
<p style="margin:6pt 0pt 0pt 0pt;">(2)&#xa0;&#xa0;The ratification or rejection of the selection of Deloitte &amp; Touche LLP as the independent registered public accountants of each Fund for the fiscal year ending September 30, 2022; and</p>
<p style="margin:6pt 0pt 0pt 0pt;">(3)&#xa0;&#xa0;The transaction of such other business as may properly come before the Annual Meeting and any adjournment(s) or postponement(s) thereof.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><b>The Board of Trustees of each Fund recommends that shareholders vote FOR the election of all nominees for election as Trustees and FOR the selection of Deloitte &amp; Touche LLP as the independent registered accountants of each Fund.</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">Although the Annual Meetings are held together, each Fund's shareholders take action independently of the other. Shareholders of record at the close of business on April 13, 2022 will be entitled to vote at the Joint Annual Meeting or at any adjournment(s) or postponement(s) thereof.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Due to COVID-19 and the related recommendations, protocols and orders issued by public health authorities and federal, state, and local governments, the date, time, location and/or means of conducting the Joint Annual Meeting may change. The Funds plan to announce these changes, if any, at www.teklacap.com and encourage you to check this website prior to the Joint Annual Meeting if you plan to attend.</p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: left;">By Order of the Board of Trustees of each Fund,</p>
<p style="margin:54pt 0pt 3pt 0pt; text-align: left;"><img src="j2225352_aa001.jpg">
</p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;">Daniel R. Omstead, PhD<br>President</p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: left;">April 18, 2022</p>
<p style="margin:12pt 0pt 0pt 0pt;"><i>Please complete, date and sign the Proxy for the shares held by you and return the Proxy in the envelope provided so that your vote can be recorded. No postage is required if the envelope is mailed in the United States. It is important that you return your signed Proxy promptly, regardless of the size of your holdings, so that a quorum may be assured.</i></p>
</div><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><b>TEKLA HEALTHCARE INVESTORS<br>TEKLA HEALTHCARE OPPORTUNITIES FUND<br>TEKLA WORLD HEALTHCARE FUND</b></p>
<p style="margin:33pt 0pt 0pt 0pt; text-align: center;"><b>JOINT PROXY STATEMENT</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">This Joint Proxy Statement is furnished in connection with the solicitation by the Board of Trustees (each a "Board," together the "Boards") of Tekla Healthcare Investors ("HQH"), Tekla Healthcare Opportunities Fund ("THQ") and Tekla World Healthcare Fund ("THW") (each a "Fund", together the "Funds") of proxies to be voted at the Joint Annual Meeting of Shareholders of the Funds to be held on June 9, 2022 (the "Annual Meeting"), and any adjournment(s) or postponement(s) thereof, for the purposes set forth in the accompanying Notice of Joint Annual Meeting, dated April 18, 2022. This Joint Proxy Statement, the Notice of Joint Annual Meeting and the Proxy Card(s) are first being mailed to shareholders on or about April 18, 2022.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Proposal 1 relates to the election of Trustees of each Fund and Proposal 2 relates to the ratification of the independent registered public accountants of each Fund.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><b>The Board of Trustees of each Fund recommends that shareholders vote FOR the election of all nominees for election as Trustees and FOR the selection of Deloitte &amp; Touche LLP as the independent registered accountants of each Fund.</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">Each Fund will furnish, without charge, a copy of its Annual Report, or the most recent Semi-Annual Report succeeding the Annual Report, if any, to a shareholder upon request. Requests may be sent to the Fund at 100 Federal Street, 19th Floor, Boston, MA 02110 or be made by calling (617) 772-8500.</p>
<p style="margin:10pt 0pt 0pt 0pt; text-align: center;"><b>Proposal 1<br>ELECTION OF TRUSTEES</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">Each Fund's Declaration of Trust, as amended to date (the "Declaration of Trust"), provides that its Board shall be divided into three classes with staggered terms. For HQH, the term of office of the Class C Trustees expires on the date of the 2022 Annual Meeting and the term of office of the Class A and Class B Trustees will expire one and two years, respectively, thereafter. For THQ, the term of office of the Class B Trustees expires on the date of the 2022 Annual Meeting and the term of office of the Class C and Class A Trustees will expire one and two years, respectively, thereafter. For THW, the term of office of the Class A Trustees expires on the date of the 2022 Annual Meeting and the term of office of the Class B and Class C Trustees will expire one and two years, respectively, thereafter. Trustees chosen to succeed the Class A, B or C Trustees whose terms are expiring will be elected for a three-year term.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Each Fund's Declaration of Trust provides that a majority of its Trustees shall fix the number of the entire Board of Trustees and that such number shall be at least three and no greater than fifteen. Each Fund's Board has fixed the number of Trustees at seven. Proxies will be voted for the election of the following nominees for HQH, THQ and THW. Each nominee has consented to serve as a Trustee if elected at the Annual Meeting. In the event that a nominee is unable to serve for any reason when </p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>1</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">the election occurs, the accompanying Proxy will be voted for such other person or persons as the applicable Fund's Board may recommend. Each nominee, except for W. Mark Watson, is presently serving as a Trustee.</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">HQH</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Class C Nominees to Serve until 2025*</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Kathleen L. Goetz</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Oleg M. Pohotsky</p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">W. Mark Watson, CPA</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">THQ</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Class B Nominees to Serve until 2025</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Rakesh K. Jain, Ph.D.</p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Daniel R. Omstead, Ph.D.</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">THW</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Class A Nominees to Serve until 2025*</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Kathleen L. Goetz</p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Oleg M. Pohotsky</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">W. Mark Watson, CPA</p></td>
<td colspan="1">&#xa0;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;">Each of the following persons, except for W. Mark Watson, is presently serving as a Trustee and has consented to so serve in the class and for the term specified below.</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">HQH</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Class A Trustees to Serve until 2023</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Jeffrey A. Bailey</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Rakesh K. Jain, Ph.D.</p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Class B Trustees to Serve until 2024</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Thomas M. Kent, CPA</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Daniel R. Omstead, Ph.D.</p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">THQ</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Class C Trustees to Serve until 2023</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Jeffrey A. Bailey</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Thomas M. Kent, CPA</p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Class A Trustees to Serve until 2024*</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Kathleen L. Goetz</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Oleg M. Pohotsky</p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">W. Mark Watson, CPA**</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">THW</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Class B Trustees to Serve until 2023</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Rakesh K. Jain, Ph.D.</p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Daniel R. Omstead, Ph.D.</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Class C Trustees to Serve until 2024</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Jeffrey A. Bailey</p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 187px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"> &#xa0;</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 131px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Thomas M. Kent, CPA</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt;">&#xa0;&#xa0;</p>
<p style="margin:6pt 0pt 0pt 0pt;"><font style="font-size: 8pt;">&#xa0;&#xa0;*&#xa0;&#xa0;William S. Reardon is also presently serving as a Trustee in this class but will retire from each Board effective as of the Annual Meeting.</font></p>
<p style="margin:2pt 0pt 0pt 0pt;"><font style="font-size: 8pt;">&#xa0;&#xa0;**&#xa0;&#xa0;W. Mark Watson has been appointed as a Trustee, effective June 9, 2022.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;">The Boards believe that each Trustee's experience, qualifications, attributes and skills on an individual basis and in combination with those of other Trustees lead to the conclusion that each Trustee should serve in such capacity. Among the attributes or skills common to all Trustees are their ability to review critically and to evaluate, question and discuss information provided to them, to interact effectively with the other Trustees, the Fund's investment adviser, the administrator and other service providers, counsel and independent registered public accounting firm, and to exercise effective and independent business judgment in the performance of their duties as Trustees. Each Trustee's ability to perform the duties of a trustee effectively has been attained and enhanced through the Trustee's education, </p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>2</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">professional training and other life experiences, such as business, consulting or public service positions and through experience from service as a member of each Fund's Board, public companies, or non-profit entities or other organizations.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><i>Jeffrey A. Bailey:</i> Mr. Bailey is a seasoned operational healthcare executive with over 30 years of leadership experience within the healthcare industry. Mr. Bailey has extensive business development and transactional expertise, with diverse leadership experiences in commercial and supply chain management, finance, business development and product development for various pharmaceutical medical device companies. He serves as Vice Chairman, on the Valuation Committee and on the Governance and Nominating Committee of each Fund. Most recently, Mr. Bailey served as chief executive officer and director of BioDelivery Sciences, a biotechnology company, from 2020-2022. He served as President and chief executive officer of IlluminOss Medical, Inc., a medical device company, from 2018 to 2020. From 2015 until 2017, Mr. Bailey served as chief executive officer of Neurovance, Inc., a biotechnology company. Previously, from 2013 through 2015, Mr. Bailey served as president and chief executive officer and as a director of Lantheus Medical Imaging, Inc., a public medical diagnostic company. Prior to 2013, Mr. Bailey held various leadership positions with several public and private pharmaceutical and medical device companies, including president and general manager at Novartis Pharmaceuticals, a multinational pharmaceutical company, and a 22-year career with Johnson &amp; Johnson, a multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company. Mr. Bailey also has extensive board member experience, having previously served on boards of directors for eight companies. Mr. Bailey currently serves as a director for Aileron Therapeutics Inc. and Madison Vaccines, Inc. Mr. Bailey holds a BA in business administration from Rutgers University.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><i>Kathleen Goetz:</i> Ms. Goetz was Vice President Head of Sales at Novartis Pharmaceuticals, a global healthcare company until 2019. Ms. Goetz serves on the Audit Committee and Valuation Committee of each Fund. Ms. Goetz brings to each Fund over 30 years of healthcare business and leadership experience, including experience working within a spectrum of diverse healthcare stakeholders and ecosystems. She brings extensive knowledge of the healthcare provider, a deep understanding of payor interests and the needs of the patient. During her 28 years with Novartis, Ms. Goetz held positions of increasing responsibility, leading marketing, sales and reimbursement teams through various stages of commercialization from pre-launch planning through to loss of exclusivity across diverse therapeutic areas. Other key roles during her time at Novartis also include National Executive Director of Strategic Accounts, Integrated Market Planning and Marketing Director, providing her with valuable experience leading organizational transformation, resourcing, forecasting, and analytics. Early in her career Ms. Goetz spent time working at Centocor Biologics. She continues to act as a mentor to future leaders and as a champion for diversity through her past work as an Executive Leadership Development mentor and a former Novartis Pharmaceuticals Women in Leadership Chair. Ms. Goetz has won numerous healthcare and business leadership awards and recognition throughout her career, including being recognized with the Healthcare Women's Business Association Rising Star Award. She continues to act as an independent consultant within the pharmaceutical and biotech industry. Ms. Goetz holds a Business Finance degree from Iowa State University.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><i>Rakesh K. Jain, Ph.D.:</i> Dr. Jain is the A. W. Cook Professor of Radiation Oncology (Tumor Biology) at Harvard Medical School and the Director of the E. L. Steele Laboratories of Tumor Biology at Massachusetts General Hospital, providing each Fund with a valuable perspective on emerging life sciences technologies. Dr. Jain co-founded XTuit Pharmaceuticals, Inc. in 2012, where he also served as a board member until 2018. He serves as the Chairman of the Governance and Nominating Committee of each Fund. Prior to joining Harvard, he was professor of chemical engineering at Columbia University and Carnegie Mellon University. Dr. Jain is regarded as a pioneer in the fields of tumor biology, drug delivery, in vivo imaging and bioengineering. Dr. Jain has authored more than </p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>3</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">750 publications. He serves on advisory panels to government, industry and academia, and has served or continues to serve on editorial advisory boards of twenty journals, including Journal of Clinical Oncology and Nature Reviews Clinical Oncology. He has received more than 90 major awards and lectureships, including the United States National Medal of Science, a Guggenheim Fellowship, the Humboldt Senior Scientist Award, the National Cancer Institute's Research Career Development Award and Outstanding Investigator Grant, the Academic Scientist of the Year Award from the Pharmaceutical Achievements Awards, the Distinguished Service Award from Nature Biotechnology and the Innovator Award from the DoD Breast Cancer Program. He is a member of all three branches of U.S. National Academies &#x2013; the Institute of Medicine, the National Academy of Engineering and the National Academy of Sciences and is a member of both the National Academy of Investors and the American Academy of Arts and Sciences. In May 2016, Dr. Jain received the National Medal of Science from President Obama at the White House.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><i>Thomas M. Kent, CPA:</i> Mr. Kent was a Partner at PricewaterhouseCoopers LLP, where he served the Investment Management Industry for over 30 years, 24 years as a Partner. In so doing, he worked with and for more than 20 different and distinct Investment Company Boards, and along side several of those Boards' service providers, including Advisors, Custodians, Accounting Agents, Transfer Agents, Security Pricing Providers, Tax advisors and others. His clients included both large and small fund groups, with both open-end and closed-end fund structures. Therefore, he provides the Funds with deep expertise in audit, valuation, operational and governance matters. He serves on the Governance and Nominating Committee and as chairman of the Audit Committee of each Fund. Mr. Kent also serves as a Director of Principal Global Investors Trust Co., and a Director of the New England Canada Business Council. Mr. Kent is a member of the American Institute of CPA's and the Massachusetts Society of CPA's where he serves on the Registered Investment Company Committee. He received his AB cum laude from Harvard College, where he majored in Economics and his MS in Accountancy from the Stern School of Business at New York University.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><i>Daniel R. Omstead, Ph.D.:</i> Dr. Omstead is President and Chief Executive Officer of Tekla Capital Management LLC (the "Adviser"), a registered investment adviser that serves as investment adviser to the Funds. Dr. Omstead is also President of the Funds and serves on their Valuation Committee. Dr. Omstead is portfolio manager for the public and restricted/venture portfolios within the Funds. Prior to joining the Adviser, Dr. Omstead was President and CEO of Reprogenesis, Inc., a private development stage biotech company which developed therapies in the field of tissue engineering and regenerative medicine. Before joining Reprogenesis, Dr. Omstead was Senior Vice President, Research and Development, at Cytotherapeutics, Inc, a public biotech company. Prior to entering the biotech industry, Dr. Omstead was employed for fourteen years in positions of increasing responsibility within the pharmaceutical industry at Ortho Pharmaceutical Corporation and at the R.W. Johnson Pharmaceutical Research Institute, both divisions of Johnson &amp; Johnson, and at Merck, Sharp and Dohme Research Laboratories, a division of Merck &amp; Co., Inc. Dr. Omstead provides each Fund with insights into both pharmaceutical and biotech companies. Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. He is an emeritus member of the Board of Directors of a non-profit agency that provides emergency shelter, housing and supportive services to homeless and low-income individuals and families in the Boston area. Dr. Omstead was also a member of the Board of Trustees at the Joslin Diabetes Center.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><i>Oleg M. Pohotsky, MBA, JD:</i> Mr. Pohotsky is a corporate finance and investment professional with over fifty years of diversified experience gained both in industry and in financial markets. Mr. Pohotsky serves as Chairman of the Board of Trustees of each Fund and also serves on each Fund's Governance and Nominating Committee. He has over 45 years of cumulative board experience in the full range of organization types: publicly-traded, privately-held, venture-backed and non-profit. He has also served </p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>4</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">as a director of a healthcare services company listed on the Nasdaq NMS where he was a member of the audit committee. In his various directorships he has also served on investment, compensation, personnel and executive committees. His career spanned over twenty years in the investment industry, both as an investment banker and as a venture capital and private equity investor, and included serving as chairman of the valuation and fairness opinion committee of a NYSE-member firm. Mr. Pohotsky also currently serves on the Board of Directors of Avangardco Investments Holdings, an LSE-listed agribusiness enterprise based in Ukraine, on the board of directors of the New America High Income Fund, Inc., a closed end fund investing in high yield securities on a leveraged basis and on the Board of Advisors of Kaufman &amp; Co., LLC, a Boston-based boutique investment banking firm, and was affiliated with GovernanceMetrics International, Inc. as a Senior Advisor. He provides each Fund with valuable experience in valuation and the financial industry. Mr. Pohotsky holds a BSChE degree from Clarkson University, a JD degree from the University of Miami and MBA from the Harvard Business School. He has also been awarded an honorary doctorate by Clarkson University.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><i>W. Mark Watson, CPA (appointed March 17, 2022 to be a Trustee effective June 9, 2022):</i> Mr. Watson is a Certified Public Accountant with over 40 years of experience in public accounting and auditing, having spent his entire career from January 1973 to June 2013 at Deloitte Touche Tohmatsu, the multinational professional services network, and its predecessor, most recently as Central Florida Marketplace Leader. Mr. Watson provides the Funds with a particular expertise in the health and life sciences sector, having played a significant role in the development of Deloitte's audit approach for health and life sciences companies and leading its national healthcare regulatory and compliance practice. He has served as lead audit partner and advisory partner on the accounts of many public companies ranging from middle market firms to Fortune 500 enterprises. Mr. Watson is a member of the American Institute of Certified Public Accountants and the Florida Institute of Certified Public Accountants. Mr. Watson is a member of the Board of Directors of Inhibitor Therapeutics, Inc., Global Health MCS and the Moffitt Cancer Center. He received his undergraduate degree in Accounting from Marquette University.</p>
<p style="margin:4pt 0pt 0pt 0pt;">The Trustees and their principal occupation for at least the last five years are set forth in the table below.</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 194px; text-align: center;" valign="bottom">
<font style="font-size: 8pt;"><b>Name, Address<sup>1</sup>, Date of Birth,<br>Length of Time Served, Principal Occupation(s)<br>During Past 5 Years and Other Directorship Held</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 340px; text-align: center;" valign="bottom">
<font style="font-size: 8pt;"><b>Position(s) Held with Funds,<br>Term of Office<sup>2</sup></b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 110px; text-align: center;" valign="bottom">
<font style="font-size: 8pt;"><b>Number of Portfolios<br>in Fund Complex<br>Overseen by Trustee</b></font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="11" style="padding:6pt .7pt 1pt 0pt; width: 644px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;"><b>INDEPENDENT TRUSTEES AND NOMINEES</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 194px; text-align: left;" valign="top">
<font style="font-size: 9pt;"><b>Jeffrey A. Bailey, </b>Born: 4/1962</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 340px; text-align: left;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Trustee since 2020; Vice Chairman since 2021</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 8px;" valign="top">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 94px; text-align: right;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">4</p></td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 8px;" valign="top">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&#xa0;</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 2103px;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">CEO, IlluminOss Inc. (2018-2020); Board Chairman, Aileron Therapeutics Inc. (since 2018); Director, Madison Vaccines, Inc. (since 2018); Director and CEO, BioDelivery Systems, Inc. (2020-2022).</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&#xa0;</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 194px; text-align: left;" valign="top">
<font style="font-size: 9pt;"><b>Kathleen L. Goetz, </b>Born: 4/1966</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 340px; text-align: left;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Trustee since 2021</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 8px;" valign="top">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 94px; text-align: right;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">4</p></td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 8px;" valign="top">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&#xa0;</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 2103px;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Vice President and Head of Sales, Novartis Pharmaceuticals (2017-2019); Executive Director of Strategic Account Management, Novartis Pharmaceuticals (2015-2016); Independent Consultant (2020-current).</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&#xa0;</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 194px; text-align: left;" valign="top">
<font style="font-size: 9pt;"><b>Rakesh K. Jain, Ph.D.,</b> Born: 12/1950</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 340px; text-align: left;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Trustee HQH since 2007; THQ since 2014; THW since 2015</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 8px;" valign="top">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 94px; text-align: right;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">4</p></td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 8px;" valign="top">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&#xa0;</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 2103px;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Director, Steele Lab of Tumor Biology at Massachusetts General Hospital (since 1991); A.W. Cook Professor of Tumor Biology (Radiation Oncology) at Harvard Medical School (since 1991); Ad hoc Consultant/Scientific Advisory Board Member for pharmaceutical/biotech companies (various times since 2002); Ad hoc Consultant, Gershon Lehman Group (since 2004); Director, Co-Founder, XTuit Pharmaceuticals, Inc. (2012-2018).</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&#xa0;</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 194px; text-align: left;" valign="top">
<font style="font-size: 9pt;"><b>Thomas M. Kent, CPA,</b> Born: 6/1953</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 340px; text-align: left;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Trustee since 2017</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 8px;" valign="top">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 94px; text-align: right;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">4</p></td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 8px;" valign="top">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 6pt 0pt;"><font style="font-size: 9pt;">Director, Principal Global Investors Trust Co. (since 2014); Trustee, Thayer Academy (2009-2018); Director, New England Canada Business Council (since 2017); Partner, PricewaterhouseCoopers LLP (1989-2013).</font></p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>5</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 194px; text-align: center;" valign="bottom">
<font style="font-size: 8pt;"><b>Name, Address<sup>1</sup>, Date of Birth,<br>Length of Time Served, Principal Occupation(s)<br>During Past 5 Years and Other Directorship Held</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 340px; text-align: center;" valign="bottom">
<font style="font-size: 8pt;"><b>Position(s) Held with Funds,<br>Term of Office<sup>2</sup></b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 110px; text-align: center;" valign="bottom">
<font style="font-size: 8pt;"><b>Number of Portfolios<br>in Fund Complex<br>Overseen by Trustee</b></font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 194px; text-align: left;" valign="top">
<font style="font-size: 9pt;"><b>Oleg M. Pohotsky, MBA, JD,</b> Born: 3/1947</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 340px; text-align: left;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Trustee HQH since 2000; THQ since 2014; THW since 2015; Chairman since 2012</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 8px;" valign="top">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 94px; text-align: right;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">4</p></td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 8px;" valign="top">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&#xa0;</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 2103px;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Consultant and Managing Partner, Right Bank Partners (since 2002); Adviser, Board Advisers, Kaufman &amp; Co. LLC (since 2008); Director, AvangardCo Investments Holdings (since 2011); Director, The New America High Income Fund, Inc. (since 2013).</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&#xa0;</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 194px; text-align: left;" valign="top">
<font style="font-size: 9pt;"><b>W. Mark Watson, CPA,</b> Born: 7/1950</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 340px; text-align: left;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Appointed March 17, 2022 to be a Trustee effective June 9, 2022</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 8px;" valign="top">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 94px; text-align: right;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">0</p></td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 8px;" valign="top">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&#xa0;</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 2103px;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Director of BioDelivery Sciences International, Inc. (2017-2022); Inhibitor Therapeutics, Inc. (since 2014); Global Health MCS (since 2014); Sykes Enterprises, Inc. (2018-2021); the Moffitt Cancer Center (since 2009).</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&#xa0;</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="11" style="padding:4pt .7pt 1pt 0pt; width: 644px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;"><b>INTERESTED TRUSTEE</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 194px; text-align: left;" valign="top">
<font style="font-size: 9pt;"><b>Daniel R. Omstead, Ph.D.,</b> Born: 7/1953</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:1pt .7pt 6pt 0pt; width: 340px; text-align: left;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">President since 2001, Trustee HQH since 2003; THQ since 2014; THW since 2015</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 8px;" valign="top">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 94px; text-align: right;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">4</p></td>
<td colspan="1" style="padding:1pt .7pt 6pt 0pt; width: 8px;" valign="top">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&#xa0;</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:0pt .7pt 6pt 0pt; width: 2103px;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">President of HQH (since 2001), of Tekla Life Sciences Investors ("HQL") (since 2001), of THQ (since 2014), of THW (since 2015); President, Chief Executive Officer and Managing Member of Tekla Capital Management LLC (Since 2002); Director: IlluminOss Medical, Inc. (2011-2020); Dynex Corporation (2011-2017); Neurovance, Inc. (2015-2017); EBI Life Sciences, Inc. (2015-2017); Euthymics Biosciences, Inc. (2015-2017); Veniti, Inc. (2015-2018); Joslin Diabetes Center (2016-2019); Decipher Biosciences Inc. (2016-2018).</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
</table>

<p style="margin:3pt 0pt 0pt 0pt;"><font style="font-size: 8pt;"><sup>1</sup>&#xa0;&#xa0;The Address for each Trustee is: c/o Tekla Capital Management LLC, 100 Federal Street, 19th Floor, Boston, Massachusetts, 02110, 617-772-8500.</font></p>
<p style="margin:1pt 0pt 0pt 0pt;"><font style="font-size: 8pt;"><sup>2</sup>&#xa0;&#xa0;Except for W. Mark Watson, each Trustee currently is serving a three year term.</font></p>
<p style="margin:1pt 0pt 0pt 0pt;"><font style="font-size: 8pt;"><sup>3</sup>&#xa0;&#xa0;Trustee considered to be an "interested person" within the meaning of the Investment Company Act of 1940, as amended (the "1940 Act"), through position or affiliation with the Adviser.</font></p>
<p style="margin:4.5pt 0pt 0pt 0pt;">The following table sets forth, for each Trustee, the aggregate dollar range of equity securities owned by such Trustee in HQH, THQ and THW and in the aggregate in all funds overseen by a Trustee in the fund complex as of March 31, 2022. The information as to beneficial ownership is based upon statements furnished by each Trustee.</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>Name of Trustee <br>or Nominee</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 0px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>Dollar Range of <br>Equity Securities <br>in HQH</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 0px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>Dollar Range of <br>Equity Securities <br>in THQ</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 0px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>Dollar Range of <br>Equity Securities <br>in THW</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 0px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>Aggregate Dollar <br>Range of Equity <br>Securities in All <br>Funds Overseen <br>by Trustee in <br>Fund Complex</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="19" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><b>Independent Trustees*</b></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Jeffrey A. Bailey</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$10,001-$50,000</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$10,001-$50,000</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$10,001-$50,000</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$50,001-$100,000</p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Kathleen L. Goetz</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$10,001-$50,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$10,001-$50,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$10,001-$50,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$10,001-$50,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Rakesh K. Jain</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">None</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">None</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">None</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">None</p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Thomas M. Kent</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$10,001-$50,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$10,001-$50,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$10,001-$50,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Over $100,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Oleg M. Pohotsky</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$10,001-$50,000</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">None</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">None</p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$10,001-$50,000</p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">William S. Reardon</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$50,001-$100,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$10,001-$50,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">$10,001-$50,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Over $100,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="19" style="padding:0pt .7pt 0pt 0pt; width: 0px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><b>Interested <br>Trustee</b></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Daniel R. Omstead</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Over $100,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Over $100,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Over $100,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 0px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">Over $100,000</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;"><font style="font-size: 8pt;">&#xa0;&#xa0;*&#xa0;&#xa0;W. Mark Watson has been appointed as a Trustee, effective June 9, 2022.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;">Although Trustees are encouraged to attend the annual meetings of shareholders to the extent they are able, none of the Funds has a formal policy with regard to Board members' attendance at annual meetings </p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>6</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">of shareholders. Last year, five of the Trustees then in office attended the 2021 joint annual meeting of shareholders telephonically, four of which participated telephonically due to the COVID-19 Pandemic.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Shareholders wishing to send communications to the Board of any Fund may communicate with members of the Board by submitting a written communication directed to the Board in care of Tekla Capital Management LLC, 100 Federal Street, 19th Floor, Boston, MA 02110.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><b>Trustees &#x2013; Leadership Structure and Oversight Responsibilities</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">Overall responsibility for general oversight of each Fund rests with the Board. The Board of each Fund is comprised of seven individuals, six of whom are not  "interested persons" of the Fund as defined in the 1940 Act ("Independent Trustees"). The Chairman and Vice Chairman of the Board are Independent Trustees. The Chairman presides at meetings of the Trustees, participates in the preparation of the agenda for meetings of the Board, and acts as a liaison between the Independent Trustees and the Fund's management between Board meetings. Except for any duties specified herein, the designation as Chairman does not impose any obligations or standards greater than or different from other Trustees.</p>
<p style="margin:6pt 0pt 0pt 0pt;">The Board of each Fund holds regular quarterly meetings each year to consider and address matters involving the Fund. The Board also may hold special meetings to address matters arising between regular meetings. The Independent Trustees also meet outside the presence of management in executive session at least quarterly and have engaged independent legal counsel to assist them in performing their oversight responsibilities.</p>
<p style="margin:6pt 0pt 0pt 0pt;">The Board of each Fund has established Audit, Governance and Nominating, Valuation and Qualified Legal Compliance Committees to assist the Board in the oversight of the management and affairs of the Fund. All of the members of these Committees are Independent Trustees, except for Dr. Omstead, who serves on the Valuation Committee. From time to time the Board may establish additional committees or informal working groups to deal with specific matters.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Each Fund is subject to a number of risks including investment, compliance, operational and valuation risks. Although the Adviser and the officers of each Fund are responsible for managing these risks on a day-to-day basis, the Board of each Fund has adopted, and periodically reviews, policies and procedures designed to address these risks. As part of its regular oversight, the Board of each Fund, directly or through a Committee, interacts with the Fund's Chief Compliance Officer, the Fund's independent public accounting firm and the Fund's legal counsel. These interactions include discussing the Fund's risk management and controls with the independent registered public accounting firm engaged by the Fund, reviewing valuation policies and procedures and the valuations of specific restricted securities, and receiving periodic reports from the Fund's Chief Compliance Officer regarding compliance matters relating to the Fund and its major service providers, including results of the implementation and testing of the Fund's and such providers' compliance programs. The Board's oversight function is facilitated by management reporting processes designed to provide information to the Board regarding the identification, assessment, and management of critical risks and the controls and policies and procedures used to mitigate those risks. The Board reviews its role in supervising the Fund's risk management from time to time and may change the manner in which it fulfills its oversight responsibilities at its discretion at any time.</p>
<p style="margin:6pt 0pt 0pt 0pt;">The Board of each Fund has determined that its leadership structure is appropriate for the Fund because it enables the Board to exercise informed and independent judgment over matters under its purview, allocates responsibility among committees in a manner that fosters effective oversight and allows the Board to devote appropriate resources to specific issues in a flexible manner as they arise. The Board periodically reviews its leadership structure as well as its overall structure, composition, and functioning and may make changes at its discretion at any time.</p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>7</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><b>Standing Committees</b></p>
<p style="margin:6pt 0pt 0pt 0pt;"><i>Audit Committee.</i> Each Fund has an Audit Committee comprised solely of Independent Trustees who are "independent" as defined in the New York Stock Exchange ("NYSE") Listing Standards. The Board of each Fund has adopted a written charter for the Audit Committee. The Audit Committee charter is available at www.teklacap.com/funds/hqh/fund/literature. The principal purpose of each Fund's Audit Committee is to assist the Board in fulfilling its responsibility to oversee management's conduct of the Fund's financial reporting process, including reviewing the financial reports and other financial information provided by the Fund, the Fund's systems of internal accounting and financial controls and the annual independent audit process.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Each Audit Committee's role is one of oversight, and it is recognized that each Fund's management is responsible for preparing each Fund's financial statements and that each Fund's independent registered public accountant is responsible for auditing those financial statements. Although each Audit Committee member must be financially literate and one member must have accounting or financial management expertise (as determined by the Board in its business judgment), Audit Committee members are not professionally engaged in the practice of accounting or auditing and are not experts in the fields of accounting or auditing, including with respect to auditor independence. Audit Committee members rely, without independent verification, on the information provided to them and on the representations made by management and each Fund's independent registered public accountants.</p>
<p style="margin:5.5pt 0pt 0pt 0pt;">The members of each Fund's Audit Committee are Mr. Kent, Mr. Reardon and Ms. Goetz. Mr. Kent is the Chairman of each Fund's Audit Committee. The Audit Committee of each Fund held four meetings during the fiscal year ended September 30, 2021.</p>
<p style="margin:5.5pt 0pt 0pt 0pt;"><i>Governance and Nominating Committee.</i> Each Fund has a Governance and Nominating Committee comprised solely of Independent Trustees who are "independent" as defined in the NYSE Listing Standards. The Committee charter is not available on the Fund's website but the written charter is included as Exhibit A to this Proxy Statement dated April 18, 2022.</p>
<p style="margin:5.5pt 0pt 0pt 0pt;">The principal missions of the Governance and Nominating Committee of each Fund are to (i) review, evaluate, and enhance the effectiveness of the Board in its role in governing the Fund and overseeing the management of the Fund and (ii) promote the effective participation of qualified individuals on the Board, on committees of the Board, and as executive officers of the Fund. The Committee shall consider the Corporate Governance Guidelines that have been approved by the Board in fulfilling its missions.</p>
<p style="margin:5.5pt 0pt 0pt 0pt;">The Committee of each Fund reviews, discusses and makes recommendations to the Board relating to those issues that pertain to the effectiveness of the Board in carrying out its responsibilities in governing the Fund and overseeing the Fund's management. The Committee makes nominations for Trustees and officers of the Fund and for membership on all committees of the Board and submits such nominations to the full Board for consideration.</p>
<p style="margin:5.5pt 0pt 0pt 0pt;">Each Fund's By-Laws require that each prospective trustee candidate have a college degree or equivalent business experience and provide a list of minimum qualifications for trustees, which include expertise, experience or relationships relevant to the business of the Fund. Each Fund's By-Laws also require that a candidate not be serving in any of various positions with another investment company (as defined in the 1940 Act) that focuses its investments in the healthcare and/or life sciences industries, unless such investment company is managed by the Fund's investment adviser or an affiliate, or in various positions with the investment adviser, sponsor or equivalent of such an investment company. Each Committee may also take into account other factors when considering and evaluating potential </p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>8</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">trustee candidates, including but not limited to: (i) availability and commitment to attend meetings and perform responsibilities of the Board; (ii) relevant industry and related experience; (iii) educational background; (iv) financial expertise; (v) the candidate's ability, judgment and expertise; and (vi) the overall diversity of the Board's composition.</p>
<p style="margin:5.5pt 0pt 0pt 0pt;">The Committee of each Fund may identify prospective trustees from any reasonable source, including, but not limited to, the consultation of third-party trustee search services. The Committee will consider potential trustee candidates recommended by shareholders, provided that the proposed candidates (i) satisfy any minimum qualifications of the Fund for its trustees; (ii) are not "interested persons" (as that term is defined in Section 2(a)(19) of the 1940 Act) of the Fund or the Adviser; and (iii) are "independent" as defined in the NYSE Listing Standards. In order to be evaluated by the Committee, trustee candidates recommended by shareholders must also meet certain eligibility requirements as set out in the Committees' charter. Other than those eligibility requirements, the Committee shall not evaluate shareholder trustee nominees in a different manner than other nominees. The standard of the Committee is to treat all equally qualified nominees in the same manner.</p>
<p style="margin:5.5pt 0pt 0pt 0pt;">All recommendations by shareholders must be received by a Fund by the deadline for submission of any shareholder proposals which would be included in the Fund's proxy statement for the next annual meeting of the Fund. Each shareholder or shareholder group must meet the requirements stated in the Committee's charter in order to recommend a candidate. A shareholder or shareholder group may not submit more than one candidate per year. When recommending a trustee candidate, shareholders must include in their notice to the Fund's Secretary: (i) the shareholder's contact information; (ii) the trustee candidate's contact information and the number of Fund shares owned by the proposed candidate; (iii) all information regarding the candidate that would be required to be disclosed in solicitations of proxies for elections of trustees required by Regulation 14A of the Securities Act of 1934, as amended (the "Exchange Act"); and (iv) a notarized letter executed by the trustee candidate, stating his or her intention to be a nominee and be named in the Fund's proxy statement, if nominated by the Board, and to serve as a trustee, if so elected. Once a recommendation has been timely received in proper form, the candidate will be asked to complete an eligibility questionnaire to assist the Fund in assessing the candidate's qualifications as a potential Independent Trustee and as someone who is "independent" under the NYSE Listing Standards. The Committee will make such determinations in its sole discretion and such determinations shall be final.</p>
<p style="margin:5.5pt 0pt 0pt 0pt;">The members of each Fund's Committee are Mr. Bailey, Dr. Jain, Mr. Kent and Mr. Pohotsky. Dr. Jain is the Chairman of the Committee. The Governance and Nominating Committee of each Fund held four meetings during the fiscal year ended September 30, 2021.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><i>Valuation Committee.</i> Each Fund's Board has delegated to the Fund's Valuation Committee general responsibility for determining, in accordance with the Fund's valuation procedures, the value of assets held by the Fund on any day on which the net asset value per share is determined. The Valuation Committee may appoint, and has appointed, a Sub-Committee made up of employees and officers of the Adviser to deal with day to day valuation decisions, subject to oversight by the Valuation Committee. The Valuation Committee shall meet as often as necessary to ensure that each action taken by the Sub-Committee is reviewed within a calendar quarter of the occurrence. In connection with its review, the Valuation Committee shall ratify or revise the pricing methodologies authorized by the Sub-Committee since the last meeting of the Valuation Committee. The Valuation Committee is charged with the responsibility of determining the fair value of the Fund's securities or other assets in situations set forth in the Fund's valuation procedures.</p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>9</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">The members of each Fund's Valuation Committee are Mr. Bailey, Ms. Goetz, Dr. Omstead and Mr. Reardon. Mr. Reardon is the Chairman of each Fund's Valuation Committee. The Valuation Committee of each Fund held four meetings during the fiscal year ended September 30, 2021.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><i>Qualified Legal Compliance Committee.</i> Each Fund has a Qualified Legal Compliance Committee ("QLCC") comprised solely of Independent Trustees. The Board of each Fund has adopted a written charter for the QLCC. The principal purpose of the Fund's QLCC is to review and respond to reports of Evidence of a Material Violation (as defined in the QLCC charter). Reporting Evidence of a Material Violation is required under the Standards of Professional Conduct for Attorneys adopted by the U.S. Securities and Exchange Commission (the "SEC") under the Sarbanes-Oxley Act of 2002 (the "Standards"). Under the Standards, if an attorney appearing and practicing before the SEC in the representation of an issuer, such as the Fund, becomes aware of Evidence of a Material Violation by the issuer or by any officer, trustee, employee or agent of the issuer, the Standards provide for the attorney to report such evidence to the issuer's QLCC forthwith. In discharging its role, the QLCC is granted the power to investigate any Evidence of a Material Violation brought to its attention with full access to all books, records, facilities and personnel of the Fund and the power to retain outside counsel, auditors or other experts for this purpose.</p>
<p style="margin:4pt 0pt 0pt 0pt;">The members of each Fund's QLCC are Dr. Jain, Mr. Pohotsky and Mr. Reardon. Mr. Reardon is the Chairman of each Fund's QLCC. Each Fund's QLCC had no cause to meet during the fiscal year ended September 30, 2021.</p>
<p style="margin:4pt 0pt 0pt 0pt;"><i>Attendance.</i> During the fiscal year ended September 30, 2021, HQH and THQ's Boards each held four meetings and THW's Board held six meetings; each Fund's Audit Committee held four meetings; each Fund's Governance and Nominating Committee held four meetings; each Fund's Valuation Committee held four meetings.</p>
<p style="margin:4pt 0pt 0pt 0pt;">Each of the incumbent Trustees attended at least 83% of the aggregate number of meetings of the Boards of each Fund during the period for which he or she served as a Trustee. Each of the incumbent Trustees attended at least 75% of the aggregate number of meetings of the Committees of the Board of each Fund on which such Trustee served during the period that he or she has served.</p>
<p style="margin:4pt 0pt 0pt 0pt;"><b>Compensation of Trustees and Officers</b></p>
<p style="margin:3pt 0pt 0pt 0pt;">For the fiscal year ended September 30, 2021, each Fund paid an annual fee of $16,250 (the annual fee was $15,000 from January 1, 2018 through December 31, 2020) to its Independent Trustees and the Chairman of the Board receives an additional annual fee of $5,000. Additionally, each Fund paid each Independent Trustee $1,000 for each Board and $750 for each Committee meeting attended in person and $250 for each Board and Committee meeting attended by telephone. The Chairman of the Audit Committee, the Valuation Committee and the Governance and Nominating Committee of each Fund each received an additional annual fee of $2,000. Independent Trustees are also reimbursed for travel expenses incurred in connection with attending such meetings. For the fiscal year ended September 30, 2021, the Independent Trustees as a group received $0 from HQH, $0 from THQ and $0 from THW for reimbursed expenses.</p>
<p style="margin:4pt 0pt 0pt 0pt;">Each Fund has entered into a Services Agreement (the "Agreement") with the Adviser. Pursuant to the terms of the Agreement, each Fund reimburses the Adviser for a portion of the payment of salary and provision of benefits to each Fund's Chief Compliance Officer. Trustees and officers of each Fund who hold positions with the Adviser receive indirect compensation from the investment advisory fee paid to the Adviser by each Fund.</p>
<p style="margin:4pt 0pt 0pt 0pt;">The following table sets forth information regarding compensation of the Trustees and Executive Officer by each Fund for the fiscal year ended September 30, 2021, but does not include reimbursed expenses as described above.</p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>10</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><b>Compensation Table</b></p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 127px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>Name of Person, Position</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="11" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 229px; text-align: center;" valign="bottom">
<font style="font-size: 8pt;"><b>Aggregate<br>Compensation<br>from each Fund</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 93px; text-align: center;" valign="bottom">
<font style="font-size: 8pt;"><b>Pension or<br>Retirement<br>Benefits Accrued<br>as part of each<br>Fund's Expenses</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 82px; text-align: center;" valign="bottom">
<font style="font-size: 8pt;"><b>Estimated<br>Annual<br>Benefits upon<br>Retirement</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 107px; text-align: center;" valign="bottom">
<font style="font-size: 8pt;"><b>Total<br>Compensation<br>from All Funds<br>in Fund Complex<br>Paid to Trustees</b></font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 127px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;"><b>Independent Trustees*</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;"><b>HQH</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 72px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;"><b>THQ</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 68px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;"><b>THW</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 93px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 82px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 107px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:1pt .7pt 0pt 0pt; width: 127px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Jeffrey A. Bailey</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 45px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">25,938</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 44px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">25,938</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 40px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">26,438</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 77px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 66px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 79px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">104,250</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:1pt .7pt 0pt 0pt; width: 127px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Rakesh K. Jain, Ph.D.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 45px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">22,938</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 44px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">22,938</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 40px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">23,438</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 77px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 66px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 79px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">92,250</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:1pt .7pt 0pt 0pt; width: 127px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Thomas M. Kent, CPA</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 45px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">25,938</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 44px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">25,938</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 40px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">26,438</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 77px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 66px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 79px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">104,250</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:1pt .7pt 0pt 0pt; width: 127px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Oleg M. Pohotsky, MBA, JD</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 45px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">31,438</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 44px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">31,438</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 40px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">31,688</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 77px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 66px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 79px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">126,000</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:1pt .7pt 0pt 0pt; width: 127px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">William S. Reardon**</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 45px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">27,938</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 44px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">27,938</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 40px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">28,438</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 77px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 66px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 79px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">112,250</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:1pt .7pt 0pt 0pt; width: 127px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Lucinda H. Stebbins***</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 45px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">21,375</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 44px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">21,375</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 40px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">21,875</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 77px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 66px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 79px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">86,000</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="27" style="padding:4pt .7pt 0pt 0pt; width: 662px;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;"><b>Interested Trustee</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:1pt .7pt 0pt 0pt; width: 127px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Daniel R. Omstead, Ph.D.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 45px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">0</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 44px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">0</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 40px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">0</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 77px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 66px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 79px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">0</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="27" style="padding:4pt .7pt 0pt 0pt; width: 662px;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;"><b>Executive Officer</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:1pt .7pt 0pt 0pt; width: 127px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 9pt;">Laura Woodward</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 45px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">124,355</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 44px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">101,235</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">$</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 40px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">50,900</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 77px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 66px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 79px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size: 9pt;">N/A</font></p></td>
<td colspan="1" style="padding:1pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;"><font style="font-size: 8pt;">&#xa0;&#xa0;*&#xa0;&#xa0;Kathleen L. Goetz was appointed as a Trustee effective December 9, 2021. W. Mark Watson has been appointed as a Trustee effective June 9, 2022.</font></p>
<p style="margin:2pt 0pt 0pt 0pt;"><font style="font-size: 8pt;">&#xa0;&#xa0;**&#xa0;&#xa0;Mr. Reardon is not standing for election at the Annual Meeting and will serve until the Annual Meeting, when he is expected to retire.</font></p>
<p style="margin:2pt 0pt 0pt 0pt;"><font style="font-size: 8pt;">&#xa0;&#xa0;***&#xa0;&#xa0;Ms. Stebbins retired on June 10, 2021.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><b>Executive Officers</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">Set forth below is information for at least the last five years with respect to the executive officers of each Fund who do not also serve as Trustees. Each officer has been elected by the Board of each Fund and serves at the pleasure of the Board.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Laura Woodward, CPA (53), 100 Federal Street, 19th Floor, Boston MA 02110: Chief Compliance Officer of HQH, HQL and Tekla Capital Management LLC (since 2009), of THQ (since 2014) and of THW (since 2015); Secretary and Treasurer, HQH and HQL (since 2009), of THQ (since 2014) and of THW (since 2015); Senior Manager, PricewaterhouseCoopers LLP (prior to 2009).</p>
<p style="margin:6pt 0pt 0pt 0pt;"><b>Required Vote</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">Each Fund's Declaration of Trust states that the Trustees shall be elected by a plurality of each Fund's shares voting at the Annual Meeting. <b>The Trustees recommend a vote FOR all nominees.</b> Plurality voting means the nominee for each seat receiving the greatest number of votes will be elected.</p>
<p style="margin:12pt 0pt 0pt 0pt; text-align: center;"><b>INFORMATION PERTAINING TO THE ADVISER</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">The Adviser is a limited liability company organized under the laws of Delaware. Under each Fund's Investment Advisory Agreement, the Adviser is responsible for the management of the Fund's assets, subject to the supervision of the Board. The Adviser manages the investments of each Fund in accordance with its investment objective and policies. The Adviser is also obligated to supervise and perform certain administrative and management services and is obligated to provide the office space, facilities, equipment and personnel necessary to perform its duties. Except for a portion of the salary of each Funds' Chief Compliance Officer, the salaries of all officers of each Fund and all personnel of each Fund or of the Adviser performing services relating to research, statistical or investment activities, and of all Trustees who are "interested persons" of the Fund or of the Adviser (as defined in the 1940 Act), are paid by the Adviser. The Adviser is located at 100 Federal Street, 19th Floor, Boston, MA 02110.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Daniel R. Omstead, Ph.D. serves as President and Chief Executive Officer of the Adviser. The address for Dr. Omstead is c/o Tekla Capital Management LLC at 100 Federal Street, 19th Floor, Boston, MA 02110.</p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>11</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><b>REPORT OF THE AUDIT COMMITTEE OF EACH FUND</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">Each Fund's Audit Committee reviewed and discussed the Fund's audited financial statements with management for the Fund's fiscal year ended September 30, 2021, and discussed with the Fund's independent registered public accountants, Deloitte &amp; Touche LLP, the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board ("PCAOB") and the SEC. Each Fund's Audit Committee received written disclosures and the letter from Deloitte &amp; Touche LLP required by applicable requirements of the PCAOB Ethics and Independence Rule 3526 regarding Deloitte &amp; Touche's communications with the Audit Committee concerning independence and discussed with Deloitte &amp; Touche LLP its independence. Based on its review and discussions with management and Deloitte &amp; Touche LLP, the Fund's Audit Committee recommended to the Board that the Fund's audited financial statements for the Fund's fiscal year ended September 30, 2021, be included in the Fund's Annual Report filed with the SEC.</p>
<p style="margin:12pt 0pt 0pt 0pt; text-align: center;"><b>SUBMITTED BY THE AUDIT COMMITTEE OF EACH FUND</b></p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: center;">Thomas M. Kent, CPA<br>Kathleen L. Goetz<br>William S. Reardon</p>
<p style="margin:12pt 0pt 0pt 0pt; text-align: center;"><b>Proposal 2<br>RATIFICATION OR REJECTION OF SELECTION OF INDEPENDENT<br>REGISTERED PUBLIC ACCOUNTANTS</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">Each Fund's Audit Committee has approved the appointment of Deloitte &amp; Touche LLP as the independent registered public accountants for the fiscal year ending September 30, 2022, and the Board of each Fund, including the Independent Trustees, subsequently unanimously approved the appointment.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Services to be performed by Deloitte &amp; Touche LLP for each Fund will consist of the examination of the annual financial statements of the Fund, consultation on financial, accounting and reporting matters, review and consultation regarding various filings with the SEC and attendance at some meetings of the Board. Deloitte &amp; Touche LLP also will perform non-audit services consisting of review of income tax returns of each Fund.</p>
<p style="margin:6pt 0pt 0pt 0pt;">A representative of Deloitte &amp; Touche LLP is expected to participate in the Joint Annual Meeting and to be available for questioning and have an opportunity to make a statement.</p>
<p style="margin:6pt 0pt 0pt 0pt;">The following tables set forth the aggregate fees billed for professional services rendered by Deloitte &amp; Touche LLP to each Fund during each Fund's two most recent fiscal years:</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 41px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>Fund</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 70px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>Fiscal year</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 84px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>Audit Fees</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 114px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>Audit-Related Fees</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 75px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>Tax Fees</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 97px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>All Other Fees</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">HQH</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 54px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">2021</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 55px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">109,150</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 85px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">0</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 46px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">6,180</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 68px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">0</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 41px;" valign="bottom">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 54px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">2020</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 21px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 55px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">103,544</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 21px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 85px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">0</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 21px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 46px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">5,830</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 21px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 68px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">0</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">THQ</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 54px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">2021</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 55px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">70,030</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 85px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">0</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 46px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">6,180</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 68px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">0</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 41px;" valign="bottom">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 54px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">2020</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 21px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 55px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">65,563</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 21px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 85px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">0</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 21px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 46px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">5,830</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 21px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 68px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">0</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 41px; background-color: #cceeff; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt">THW</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 54px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">2021</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 55px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">70,030</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 85px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">0</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 46px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">11,655</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 68px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">0</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:0pt .7pt 0pt 0pt; width: 41px;" valign="bottom">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 54px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">2020</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 21px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 55px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">65,563</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 21px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 85px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">0</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 21px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 46px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">13,330</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 21px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">$</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 68px; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">0</p></td>
<td colspan="1" style="padding:0pt .7pt 0pt 0pt; width: 8px;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>12</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">All of the services described in the table above were approved by each Audit Committee pursuant to its pre-approval policies and procedures (the "Pre-Approval Policies and Procedures") which are summarized below to the extent that such services were required to be pre-approved by each Audit Committee.</p>
<p style="margin:6pt 0pt 0pt 0pt;">The aggregate non-audit fees billed by Deloitte &amp; Touche LLP for services rendered to each Fund and to the Adviser, or an affiliate thereof that provides ongoing services to each Fund, amounted to $6,180, $6,180 and $11,655 for the fiscal year ended September 30, 2021 for HQH, THQ and THW, respectively, and to  $5,830, $5,830 and $13,330 for the fiscal year ended September 30, 2020 for HQH, THQ and THW, respectively.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Each Fund's Audit Committee has adopted Pre-Approval Policies and Procedures pursuant to which the Committee pre-approves all audit and non-audit services provided by the Fund's independent auditor (the "Auditor") and any non-audit services provided by the Auditor to the Fund's investment adviser and service affiliates ("Service Affiliates") during the period of the Auditor's engagement to provide audit services to the Fund, if those services directly impact the Fund's operations and financial reporting. Audit services include those typically associated with the annual audit such as evaluation of internal controls. Non-Audit services include certain services that are audit-related, such as consultations regarding financial accounting and reporting standards and tax services. Certain services may not be provided by the Auditor to the Fund's or the Fund's Service Affiliates without jeopardizing the Auditor's independence. These services are deemed prohibited services and include certain management functions; human resources services; broker-dealer, investment adviser or investment banking services; legal services; and expert services unrelated to the audit. Other services are conditionally prohibited and may be provided, if the Audit Committee reasonably concludes that the results of the services will not be subject to audit procedures during an audit of the Fund's financial statements. These types of services include bookkeeping; financial information systems design and implementation; appraisal or valuation services; actuarial services; and internal audit outsourcing services.</p>
<p style="margin:6pt 0pt 0pt 0pt;">The Pre-Approval Policies and Procedures of each Fund's Audit Committee require Audit Committee approval of the engagement of the Auditor for each fiscal year and approval of the engagement by at least a majority of the Fund's Independent Trustees. In determining whether to engage the Auditor for its audit services, each Fund's Audit Committee will consider the Auditor's proposed fees for the engagement, in light of the scope and nature of the audit services that the Fund will receive. The Pre-Approval Policies and Procedures also permit each Fund's Audit Committee to pre-approve the provisions of types or categories of permissible non-audit services for the Fund and its Service Affiliates on an annual basis at the time of the Auditor's engagement and on a project-by-project basis. At the time of the annual engagement of each Fund's Auditor, each Audit Committee is to receive a list of the categories of expected non-audit services with a description and an estimated budget of fees. In their pre-approval, each Audit Committee should determine that the provision of the service is consistent with, and will not impair, the ongoing independence of the Auditor and set any limits on fees or other conditions they find appropriate. Non-audit services may also be approved on a project-by-project basis by each Audit Committee consistent with the same standards for determination and information.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Each Audit Committee may also appoint a member of each Committee to pre-approve non-audit services that have not been pre-approved or material changes in the nature or cost of any non-audit services previously pre-approved. The member may not pre-approve any project the estimated budget (or budgeted range) of fees of which exceed or may exceed $15,000. Any actions by the member are to be ratified by the Audit Committee by the time of its next scheduled meeting. Each Fund's </p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>13</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">Pre-Approval Policies and Procedures are reviewed annually by the Fund's Audit Committee, and the Fund maintains a record of the decisions made by the Committee pursuant to these procedures.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><b>Required Vote</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">The selection of Deloitte &amp; Touche LLP as each Fund's independent public accountants for the fiscal year ending September 30, 2022 is submitted to shareholders for ratification and requires approval by a majority of each Fund's shares voting at the Joint Annual Meeting. <b>The Trustees recommend a vote FOR the selection of Deloitte &amp; Touche LLP as the independent registered public accountants of each Fund.</b></p>
<p style="margin:12pt 0pt 0pt 0pt; text-align: center;"><b>INFORMATION PERTAINING TO THE CUSTODIAN AND ADMINISTRATOR AND <br>TRANSFER AGENT, DIVIDEND DISBURSING AGENT AND REGISTRAR</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">Each Fund's securities and cash are held under a custodian contract by State Street Bank and Trust Company ("State Street"), whose principal business address is One Lincoln Street, Boston, MA 02111. State Street is also the Administrator of each Fund and also performs certain accounting related functions for each Fund, including calculation of net asset value and net income.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Computershare Inc. serves as Dividend Disbursing Agent. Computershare Trust Company, N.A., a fully owned subsidiary of Computershare Inc., serves as (1) the Plan Agent for each Fund's Dividend Reinvestment Plan and (2) the Transfer Agent and Registrar for Shares of each Fund. Computershare Trust Company, N.A. and Computershare Inc. have their principal business at 150 Royall Street, Canton, MA 02021.</p>
<p style="margin:12pt 0pt 0pt 0pt; text-align: center;"><b>SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">Section 16(a) of the Exchange Act and Section 30(j) of the 1940 Act, as applied to each Fund, require the Fund's officers and trustees, investment manager, affiliates of the investment manager, and persons who beneficially own more than ten percent of a registered class of the Fund's outstanding securities ("Reporting Persons") to file reports of ownership of the Fund's securities and changes in such ownership with the SEC and the NYSE. Such persons are required by SEC regulations to furnish the Fund with copies of all such filings.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Based solely upon its review of the copies of such forms received by it, and written representations from certain Reporting Persons that no year-end reports were required for those persons, each Fund believes that during the fiscal year ended September 30, 2021, its Reporting Persons complied with all applicable filing requirements.</p>
<p style="margin:12pt 0pt 0pt 0pt; text-align: center;"><b>OTHER BUSINESS</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">As of the date of this Joint Proxy Statement, the Board of each Fund is not aware that any matters are to be presented for action at the Joint Annual Meeting other than those described above. Should other business properly be brought before the Joint Annual Meeting, it is intended that the accompanying Proxy will be voted thereon in accordance with the judgment of the persons named as proxies.</p>
<p style="margin:12pt 0pt 0pt 0pt; text-align: center;"><b>PROXIES AND VOTING AT THE JOINT ANNUAL MEETING</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">Shareholders who execute proxies may revoke them at any time before they are voted by written notice to the Secretary of the Fund at 100 Federal Street, 19th Floor, Boston, MA 02110, or by casting a vote at the Joint Annual Meeting. Instructions on how to attend the meeting and vote in person </p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>14</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">can be obtained by calling (617) 772-8500. All valid proxies received prior to the Joint Annual Meeting, or any adjournment(s) or postponements(s) thereof, will be voted at the Joint Annual Meeting and any adjournments or postponements thereof.</p>
<p style="margin:6pt 0pt 0pt 0pt;">The representation in person or by proxy of a majority of the outstanding shares of each Fund is necessary to constitute a quorum for transacting business at the Joint Annual Meeting. For purposes of determining the presence of a quorum, abstentions and broker "non-votes" will be treated as shares that are present. Broker non-votes are proxies received by each Fund from brokers or nominees when the broker or nominee has neither received instructions from the beneficial owner or other persons entitled to vote nor has discretionary power to vote on a particular matter. Proposals 1 and 2 to be voted upon by the shareholders involve matters that the NYSE considers to be routine and within the discretion of brokers to vote if no customer instructions are received.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Proposal 1 requires the approval of a plurality of shares voting at the Joint Annual Meeting (i.e., the nominee for each seat receiving the greatest number of votes will be elected). </p>
<p style="margin:6pt 0pt 0pt 0pt;">Proposal 2 requires the approval of a majority of all votes validly cast at the Joint Annual Meeting.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Abstentions and broker non-votes will be considered shares present or represented by a proxy but will not be considered shares voted. As a result, they will have no effect on Proposals 1 or 2.</p>
<p style="margin:6pt 0pt 0pt 0pt;">Matters on which a choice has been provided will be voted as indicated on the proxy card and, if no instruction is given, the persons named as proxies will vote the shares represented thereby FOR all nominees for election as Trustee and FOR Proposal 2 and will use their best judgment in connection with the transaction of such other business as may properly come before the Joint Annual Meeting or any adjournment(s) or postponement(s) thereof.</p>
<p style="margin:6pt 0pt 0pt 0pt;">In the event that sufficient votes in accordance with the Trustees' recommendations on any Proposal are not received by June 9, 2022 or the necessary quorum has not been obtained, or if other matters arise requiring shareholder attention, the persons named as proxies on the enclosed proxy card may propose one or more adjournments of the Joint Annual Meeting to permit further solicitation. Any such adjournment will require approval by a majority of the votes validly cast on the matter at the session of the Joint Annual Meeting to be adjourned. When voting on a proposed adjournment, the persons named as proxies will vote FOR the proposed adjournment all shares that they are entitled to vote with respect to each item, unless directed to vote AGAINST an item, in which case such shares will be voted AGAINST the proposed adjournment with respect to that item. A shareholder vote may be taken on one or more items prior to such adjournment, if sufficient votes have been received and it is otherwise appropriate. Abstentions and broker non-votes will be disregarded for purposes of voting on adjournment.</p>
<p style="margin:6pt 0pt 0pt 0pt;">As of April 13, 2022, there were:</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; width: 176px;" valign="bottom">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 77px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>HQH</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>THQ</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>THW</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:4pt .7pt 0pt 0pt; width: 176px; background-color: #cceeff; text-align: left;" valign="bottom">
Shares of beneficial interest issued <br>and outstanding</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 61px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">46,343,900</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 60px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">41,356,058</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 60px; background-color: #cceeff; text-align: right;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap">37,380,013</p></td>
<td colspan="1" style="padding:4pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;" valign="bottom">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;">Shareholders of each Fund will be entitled to one vote for each share held. Only shareholders of record at the close of business on April 13, 2022, the record date, will be entitled to vote at the Joint Annual Meeting. As of March 31, 2022, the Trustees and officers of each Fund individually and as a group beneficially owned less than 1% of the outstanding voting securities of the Fund. To the best of each </p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>15</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">Fund's knowledge, based upon filings made with the SEC, as of April 11, 2022, the below persons or groups beneficially owned more than 5% of the voting securities of the Fund:</p>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; ">
<tr>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 88px; text-align: left;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>(1) Title of class</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 175px; text-align: center;" valign="bottom">
<font style="font-size: 8pt;"><b>(2) Name and address of<br>beneficial owner</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 124px; text-align: center;" valign="bottom">
<font style="font-size: 8pt;"><b>(3) Amount and nature of<br>beneficial ownership</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 115px; text-align: center;" valign="bottom">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size: 8pt;"><b>(4) Percent of class</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" style="padding:2pt .7pt 6pt 0pt; width: 88px; background-color: #cceeff; text-align: left;" valign="top">
HQH Common <br>Stock</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:2pt .7pt 6pt 0pt; width: 175px; background-color: #cceeff; text-align: left;" valign="top">
Morgan Stanley Smith Barney LLC<br>1585 Broadway<br>New York, NY 10036</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:2pt .7pt 6pt 0pt; width: 108px; background-color: #cceeff; text-align: left;" valign="top">
<p style="margin:0pt 0pt 0pt 0pt">3,257,060 shares</p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" style="padding:2pt .7pt 6pt 0pt; width: 83px; background-color: #cceeff; text-align: left;" valign="top">
7.2%</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:12pt 0pt 0pt 0pt; text-align: center;"><b>PROPOSALS FOR 2023 ANNUAL MEETING</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">Shareholder proposals for each Fund's 2023 Annual Meeting must be received by U.S. mail, a private courier service, or hand delivery and be addressed to the Fund's Secretary at the Fund's executive offices at 100 Federal Street, 19th Floor, Boston, Massachusetts 02110 no later than December 20, 2022 for inclusion in the Fund's 2023 proxy statement and form of proxy, unless the meeting date is more than 30 days before or after June 9, 2023, in which case the proposal must be submitted a reasonable time before the time the Fund begins to print and send its proxy materials for the 2023 Annual Meeting. Submission of such proposals does not insure that they will be included in the Fund's 2023 proxy statement or submitted for a vote at the Fund's 2023 Annual Meeting.</p>
<p style="margin:6pt 0pt 0pt 0pt;">In addition, shareholder proposals for each Fund's 2023 Annual Meeting (other than proposals submitted for inclusion in the Fund's 2023 proxy statement) must be submitted to the Fund's Secretary between February 9, 2023 and March 11, 2023, unless the meeting date is more than 30 days before or after June 9, 2023, in which case the proposal must be submitted by the later of the close of business on (1) the date 90 days prior to the 2022 Annual Meeting date or (2) the tenth business day following the date on which the 2023 Annual Meeting date is first publicly announced or disclosed. </p>
<p style="margin:12pt 0pt 0pt 0pt; text-align: center;"><b>GENERAL</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">Each Fund will pay the cost of preparing, printing and mailing the enclosed proxy card(s) and Joint Proxy Statement and all other costs incurred in connection with the solicitation of proxies, including any additional solicitation made by letter, internet, telephone or telegraph. The solicitation of proxies will be largely by mail. In addition, certain officers of the Fund and certain employees of the Adviser, who will receive no compensation for their services other than their regular salaries, may solicit the return of proxies personally or by telephone or facsimile. Banks, brokerage houses, nominees and other fiduciaries will be requested to forward the proxy soliciting materials to the beneficial owners of the shares of each Fund. Each Fund may reimburse brokerage houses, nominees and other fiduciaries for postage and reasonable expenses incurred by them in forwarding of proxy material to beneficial owners.</p>
<p style="margin:6pt 0pt 0pt 0pt;">A number of banks, brokers and financial institutions have instituted "householding". Under this practice, only one Joint Proxy Statement may be delivered to multiple shareholders who share the same address and satisfy other conditions. Each Fund will deliver promptly a separate copy of this Joint Proxy Statement to a shareholder at a shared address upon request. To request a separate copy of this Joint Proxy Statement, write or call the Fund at the address and phone number set forth above.</p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>16</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><b>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY<br>MATERIALS FOR THE SHAREHOLDER MEETING TO BE HELD ON JUNE 9, 2022</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">The Joint Proxy Statement for the Joint Annual Meeting of Shareholders of Tekla Healthcare Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund and form of proxy are available at www.proxy-direct.com/TKL-32606.</p>
<p style="margin:12pt 0pt 0pt 0pt; text-align: left;">TEKLA HEALTHCARE INVESTORS<br>TEKLA HEALTHCARE OPPORTUNITIES FUND<br>TEKLA WORLD HEALTHCARE FUND</p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: left;">April 18, 2022</p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>17</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><b>EXHIBIT A</b></p>
<p style="margin:6pt 0pt 0pt 0pt;"><b><font style="text-decoration:underline">Governance and Nominating Committee Charter</font></b></p>
<p style="margin:6pt 0pt 0pt 0pt;">For convenience, this Charter refers to the Funds and their respective Boards of Trustees (each the "Board"), and their respective Governance and Nominating Committees (each the "Committee" or the "Governance and Nominating Committee") in the singular. However, this Charter applies to each Fund, its Board and its Committee independently.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><b><i>Committee Membership</i></b></p>
<p style="margin:6pt 0pt 0pt 0pt;">The Committee shall consist entirely of trustees of the Fund who (1) are not "interested persons," as that term is defined in the Investment Company Act of 1940, as amended (the "1940 Act"), of the Fund or the Fund's investment adviser and (2) are "independent" as defined in the New York Stock Exchange ("NYSE") Listing Standards ("Independent Trustees"). The President of the Fund, although not a member of the Committee, will cooperate with the Committee by assisting the Committee to discharge its responsibilities, including by recommending candidates and recruiting them for the Board or to serve as executive officers of the Fund.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><b><i>Missions</i></b></p>
<p style="margin:6pt 0pt 0pt 0pt;">The principal missions of the Committee are (i) to review, evaluate, and enhance the effectiveness of the Board in its role in governing the Fund and overseeing the management of the Fund and (ii) to promote the effective participation of qualified individuals on the Board, on committees of the Board, and as executive officers of the Fund. The Committee shall consider the Corporate Governance Guidelines attached to this Charter as Appendix A in fulfilling its missions.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><b><i>Governance Function</i></b></p>
<p style="margin:6pt 0pt 0pt 0pt;">The Committee shall review, discuss, and make recommendations to the Board relating to those issues that pertain to the effectiveness of the Board in carrying out its responsibilities in governing the Fund and overseeing the management of the Fund. These may include, but are not limited to, issues relating to:</p>
<p style="margin:6pt 0pt 0pt 0pt;">1.&#xa0;&#xa0;the selection of the Fund's investment adviser (the "Adviser") and approval of the Fund's investment advisory contract;</p>
<p style="margin:6pt 0pt 0pt 0pt;">2.&#xa0;&#xa0;the selection and approval of the Fund's outside counsel ("Fund Counsel");</p>
<p style="margin:6pt 0pt 0pt 0pt;">3.&#xa0;&#xa0;the composition of the Board, including:</p>
<p style="margin:6pt 0pt 0pt 0pt;">(a)&#xa0;&#xa0;the size of the Board and the qualifications and representative areas of expertise of the members of the Board; and</p>
<p style="margin:6pt 0pt 0pt 0pt;">(b)&#xa0;&#xa0;retirement and succession policies relating to members of the Board;</p>
<p style="margin:6pt 0pt 0pt 0pt;">4.&#xa0;&#xa0;the members of the Board, including:</p>
<p style="margin:6pt 0pt 0pt 0pt;">(a)&#xa0;&#xa0;guidelines relating to ownership of shares of the Fund by members of the Board;</p>
<p style="margin:6pt 0pt 0pt 0pt;">(b)&#xa0;&#xa0;whether members of the Board may not serve in a similar capacity on the board of a registered investment company (i) which is not sponsored or advised by the Adviser or its affiliates and (ii) which the Committee in its discretion has determined to be competitive with the Fund taking into account such registered investment company's investment mandate;</p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>18</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">(c)&#xa0;&#xa0;continuing education of members of the Board; and</p>
<p style="margin:6pt 0pt 0pt 0pt;">(d)&#xa0;&#xa0;identification of best practices for members of the Board;</p>
<p style="margin:6pt 0pt 0pt 0pt;">5.&#xa0;&#xa0;the meetings of the Board, including:</p>
<p style="margin:6pt 0pt 0pt 0pt;">(a)&#xa0;&#xa0;coordination with the Chairman of the Board in developing the agenda for the meetings of the Board, with the assistance of the Adviser and Fund Counsel;</p>
<p style="margin:6pt 0pt 0pt 0pt;">(b)&#xa0;&#xa0;frequency of meetings of the Board; and</p>
<p style="margin:6pt 0pt 0pt 0pt;">(c)&#xa0;&#xa0;Board meeting attendance policies;</p>
<p style="margin:6pt 0pt 0pt 0pt;">6.&#xa0;&#xa0;the role of the Independent Trustees, including:</p>
<p style="margin:6pt 0pt 0pt 0pt;">(a)&#xa0;&#xa0;limitations on the ability of Independent Trustees to act and function independently of the Board and the Adviser; and</p>
<p style="margin:6pt 0pt 0pt 0pt;">(b)&#xa0;&#xa0;the quality of information received by the Independent Trustees;</p>
<p style="margin:6pt 0pt 0pt 0pt;">7.&#xa0;&#xa0;compensation for Independent Trustees;</p>
<p style="margin:6pt 0pt 0pt 0pt;">8.&#xa0;&#xa0;the role of the committees of the Board, including:</p>
<p style="margin:6pt 0pt 0pt 0pt;">(a)&#xa0;&#xa0;number and type of committees; and</p>
<p style="margin:6pt 0pt 0pt 0pt;">(b)&#xa0;&#xa0;periodic approval of the charter and scope of the responsibilities of each committee;</p>
<p style="margin:6pt 0pt 0pt 0pt;">9.&#xa0;&#xa0;the relationship between the Board and management, including:</p>
<p style="margin:6pt 0pt 0pt 0pt;">(a)&#xa0;&#xa0;oversight of and communication with management;</p>
<p style="margin:6pt 0pt 0pt 0pt;">(b)&#xa0;&#xa0;coordination with management to ensure that management has developed an appropriate plan to deal with succession and potential crisis management situations; and</p>
<p style="margin:6pt 0pt 0pt 0pt;">10.&#xa0;&#xa0;Board self-evaluation.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><b><i>Nominating Function &#x2013; Board</i></b></p>
<p style="margin:6pt 0pt 0pt 0pt;">1.&#xa0;&#xa0;The Committee shall make nominations for trustees and officers of the Fund and submit such nominations to the full Board. The Committee shall evaluate candidates' qualifications for such positions and, in the case of candidates for election to the Board, whether they would qualify as Independent Trustees. The Committee shall also consider the effect of any relationships beyond those delineated in the 1940 Act that might impair independence (e.g. business, financial or family relationships with the Adviser). In determining candidates' qualifications for Board membership, the Committee shall consider factors which may be delineated in this Charter or the Fund's By-Laws and may consider such other factors as it may determine to be relevant to fulfilling the role of being a member of the Board.</p>
<p style="margin:6pt 0pt 0pt 0pt;">2.&#xa0;&#xa0;The Committee may consider potential trustee candidates recommended by shareholders, provided that the proposed candidates: (i) satisfy any minimum qualifications of the Fund for its trustees; and (ii) qualify as Independent Trustees. In order for the Committee to evaluate any nominee recommended by a shareholder or shareholder group, potential trustee candidates and nominating shareholders or shareholder groups must satisfy the requirements provided in Appendix B to this Charter. The Committee shall not otherwise evaluate shareholder trustee nominees in a different manner than other nominees, and the standard of the Committee is to treat all equally qualified </p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>19</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">nominees in the same manner. Once a nomination has been timely received in proper form, the nominee will be asked to complete an eligibility questionnaire to assist the Committee in assessing the nominee's qualifications as a potential Independent Trustee. The Committee will make such determinations in its sole discretion and such determinations shall be final.</p>
<p style="margin:6pt 0pt 0pt 0pt;">3.&#xa0;&#xa0;The Committee may identify prospective trustees from any reasonable source, including, but not limited to, the consultation of third-party trustee search services.</p>
<p style="margin:6pt 0pt 0pt 0pt;">4.&#xa0;&#xa0;The Committee requires that each prospective trustee have a college degree or equivalent business experience. In addition to the requirements delineated in the Fund's By-Laws, the Committee may take into account a wide variety of factors in considering prospective trustees, including (but not limited to): (i) availability and commitment of a candidate to attend meetings and perform his or her responsibilities on the Board; (ii) relevant industry and related experience; (iii) educational background; (iv) financial expertise; (v) the candidate's ability, judgment and expertise; and (vi) overall diversity of the Board's composition.</p>
<p style="margin:6pt 0pt 0pt 0pt;">6.&#xa0;&#xa0;The Committee shall evaluate the participation and contribution of each trustee coming to the end of his or her term before deciding whether to recommend reelection. The Committee may seek the views of other trustees to assist them in this evaluation.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><b><i>Nominating Function &#x2013; Committees</i></b></p>
<p style="margin:6pt 0pt 0pt 0pt;">The Committee shall make nominations for membership on all committees of the Board and submit such nominations to the full Board and shall review committee assignments as necessary.</p>
<p style="margin:6pt 0pt 0pt 0pt;"><b><i>Other Powers and Responsibilities</i></b></p>
<p style="margin:6pt 0pt 0pt 0pt;">1.&#xa0;&#xa0;The Committee shall meet at least annually so it can carry out its review of the investment advisory agreement, recommend the selection of an Adviser, and consider Board and Committee nominations. The Committee shall meet at such other time or times as the Committee or the Board may determine appropriate or necessary and is empowered to hold special meetings as circumstances require.</p>
<p style="margin:6pt 0pt 0pt 0pt;">2.&#xa0;&#xa0;The Committee shall have the resources and authority appropriate to discharge its responsibilities, including authority to utilize Fund Counsel and to retain experts or other persons with specific competence at the expense of the Fund.</p>
<p style="margin:6pt 0pt 0pt 0pt;">3.&#xa0;&#xa0;The Committee shall review this Charter periodically and recommend any changes to the Board.</p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>20</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><b>APPENDIX A</b></p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: center;"><b>Corporate Governance Guidelines</b></p>
<p style="margin:6pt 0pt 0pt 0pt;">1.&#xa0;&#xa0;General</p>
<p style="margin:6pt 0pt 0pt 0pt;">The intent is that the Board shall, wherever possible, comply in its structure and operations with the guidelines issued by the NYSE and the Securities and Exchange Commission ("SEC").</p>
<p style="margin:6pt 0pt 0pt 0pt;">2.&#xa0;&#xa0;Board Composition</p>
<p style="margin:6pt 0pt 0pt 0pt;">(a)&#xa0;&#xa0;The Fund's Declaration of Trust, as amended, provides that the Trustees shall be at least three and not more than fifteen in number, as fixed by the Trustees, and the number of Trustees is currently fixed at seven.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(b)&#xa0;&#xa0;Independent Trustees shall represent at least 75% of Board membership.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(c)&#xa0;&#xa0;The President of the Adviser, and such other officers of the Adviser as the Board may designate, shall be included among those nominated for Board membership, but they shall not be considered as Independent Trustees.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(d)&#xa0;&#xa0;The Board shall seek to be broadly representative of the various skills and experience deemed necessary to ensure sound oversight of the Fund.</p>
<p style="margin:6pt 0pt 0pt 0pt;">3.&#xa0;&#xa0;Selection of Chairman of the Board</p>
<p style="margin:6pt 0pt 0pt 0pt;">The Board shall annually elect its own Chairman from among those Independent Trustees elected by the shareholders. This election shall take place at the first Board meeting following the annual meeting of shareholders or upon the initiative of a two-thirds majority of the trustees.</p>
<p style="margin:6pt 0pt 0pt 0pt;">4.&#xa0;&#xa0;General Expectations</p>
<p style="margin:6pt 0pt 0pt 0pt;">(a)&#xa0;&#xa0;In serving as a trustee, each trustee must exercise duties of care and loyalty to the Fund.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(b)&#xa0;&#xa0;Each Independent Trustee is expected to be knowledgeable about Fund business and financial operations through Board and Board committee meetings and personal inquiry and observation, and to contribute to the Board's oversight of the Fund's investment performance.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(c)&#xa0;&#xa0;Each trustee is expected to devote sufficient time and attention to carrying out his or her duties and responsibilities as a trustee of the Fund and to ensure that other commitments or responsibilities do not materially interfere with his or her duties and responsibilities to the Fund.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(d)&#xa0;&#xa0;The criteria to be used to evaluate candidates to serve as trustees, which will be reviewed from time to time by the Board or the Governance and Nominating Committee, will stress personal and professional integrity, sound judgment, relevant experience, a proven record of professional accomplishment, and a commitment to devote sufficient time and attention to Fund matters, among other relevant factors. In the case of a candidate to serve as an Independent Trustee, independence will be required in terms of both the letter and spirit of applicable law.</p>
<p style="margin:6pt 0pt 0pt 0pt;">5.&#xa0;&#xa0;Retirement of Trustees</p>
<p style="margin:6pt 0pt 0pt 0pt;">Trustees shall serve for a three-year term upon nomination by the Committee and election by the shareholders. No person may be nominated for election to the Board, if that person is 75 years of age or older at the time of consideration, unless such nomination is approved by at least 66<font style="font-size: 5pt;"><sup>2</sup></font>/<font style="font-size: 5pt;"><sub>3</sub></font>% of the Independent Trustees.</p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>21</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">6.&#xa0;&#xa0;Independent Trustee Sessions</p>
<p style="margin:6pt 0pt 0pt 0pt;">Independent Trustees are expected to meet in separate session at least once each quarter, typically in conjunction with the regularly scheduled Board meeting for that quarter. In such sessions, Independent Trustees are expected to engage in candid discussions about Fund management performance and other sensitive matters deemed appropriate.</p>
<p style="margin:6pt 0pt 0pt 0pt;">7.&#xa0;&#xa0;Independent Trustee Authority to Hire Staff</p>
<p style="margin:6pt 0pt 0pt 0pt;">Independent Trustees may hire their own staff to the extent deemed necessary to help Independent Trustees deal with matters on which they deem outside assistance to be necessary.</p>
<p style="margin:6pt 0pt 0pt 0pt;">8.&#xa0;&#xa0;Committees of the Board</p>
<p style="margin:6pt 0pt 0pt 0pt;">(a)&#xa0;&#xa0;The Board shall have four Committees:</p>
<p style="margin:6pt 0pt 0pt 0pt;">(i)&#xa0;&#xa0;an Audit Committee;</p>
<p style="margin:6pt 0pt 0pt 0pt;">(ii)&#xa0;&#xa0;a Valuation Committee;</p>
<p style="margin:6pt 0pt 0pt 0pt;">(iii)&#xa0;&#xa0;a Governance and Nominating Committee; and</p>
<p style="margin:6pt 0pt 0pt 0pt;">(iv)&#xa0;&#xa0;a Qualified Legal Compliance Committee.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(b)&#xa0;&#xa0;A Compensation Committee, generally required by SEC and NYSE guidelines, is not deemed necessary as personnel of the Adviser serve as the Fund's officers, and the compensation of such personnel is determined and payable by the Adviser (with the exception of the Fund's Chief Compliance Officer). Oversight of the Adviser's budget, including compensation, shall be a factor in the Board's approval of the Adviser's investment advisory contract.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(c)&#xa0;&#xa0;Each of the Board's committees shall have a charter (or policies and procedures), which shall have been approved by the Board. The Governance and Nominating Committee shall review periodically each such charter and recommend any changes to the Board. The Audit Committee shall review its charter annually to comply with NYSE Listing Standards and recommend any changes to the Board.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(d)&#xa0;&#xa0;Committee Chairman and members shall be nominated by the Governance and Nominating Committee and approved by the Board.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(e)&#xa0;&#xa0;The Audit Committee, Governance and Nominating Committee and Qualified Legal Compliance Committee shall each consist solely of Independent Trustees.</p>
<p style="margin:6pt 0pt 0pt 0pt;">9.&#xa0;&#xa0;Board Meetings</p>
<p style="margin:6pt 0pt 0pt 0pt;">(a)&#xa0;&#xa0;The Board is expected to meet no less than four times per year, including one meeting which coincides with the annual meeting of shareholders.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(b)&#xa0;&#xa0;Trustees are expected to attend all Board meetings in person. Where conflicts prevent attendance in person, trustees may attend by telephone or video conference. It is expected that, during their term, trustees shall attend no fewer than 50% of Board meetings in person and no less than 75% of meetings where a majority of Independent Trustees must be present in person.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(c)&#xa0;&#xa0;Agendas for Board meetings shall be proposed by the Adviser and Fund Counsel and approved by the Chairman of the Board at least two weeks in advance of each Board meeting and one month in advance of the annual meeting of shareholders.</p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>22</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">(d)&#xa0;&#xa0;Minutes for each Board meeting shall be prepared and circulated within six weeks of each Board meeting and shall highlight items on which follow-up action is required.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(e)&#xa0;&#xa0;In their role as trustees, all trustees owe a duty of loyalty to the shareholders and to the Fund. This duty of loyalty mandates that the best interests of the shareholders and the Fund take precedence over any interests possessed by a trustee. In the event of any conflict of interests, a trustee shall promptly disclose such conflict to the Chairman of the Board and Fund Counsel and recuse him or herself from any discussions or votes involving the conflict.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(f)&#xa0;&#xa0;The proceedings of the Board and its committees are confidential. Each trustee shall maintain the confidentiality of information received as part of his or her duty as a trustee.</p>
<p style="margin:6pt 0pt 0pt 0pt;">10.&#xa0;&#xa0;Board Access to Senior Management and Key Service Providers</p>
<p style="margin:6pt 0pt 0pt 0pt;">Trustees must have reasonable access to Fund management and senior management of the Adviser. Trustees must have reasonable access to Fund Counsel, auditors, and other key service providers. Independent Trustees must have reasonable access to independent legal counsel. The Chairman of the Board is responsible for fostering constructive interaction between Fund management and the Board. The chairman of each committee is responsible for fostering constructive interaction between Fund management and the committee.</p>
<p style="margin:6pt 0pt 0pt 0pt;">11.&#xa0;&#xa0;Trustee Education</p>
<p style="margin:6pt 0pt 0pt 0pt;">(a)&#xa0;&#xa0;New trustees will review background materials and participate in an orientation program that includes discussions with incumbent trustees and senior management. Topics covered will include investment operations, compliance practices and operations, financial operations, and organizational structure.</p>
<p style="margin:6pt 0pt 0pt 0pt;">(b)&#xa0;&#xa0;Continuing trustee education will be a standing agenda item for each regularly scheduled meeting to cover timely topics based on industry developments and Fund operations.</p>
<p style="margin:6pt 0pt 0pt 0pt;">12.&#xa0;&#xa0;Review of Strategic Planning</p>
<p style="margin:6pt 0pt 0pt 0pt;">The Board will periodically review the continued organizational strength of the Fund, Fund management, and the Adviser to ensure the Fund's continued short-term and long-term viability. At least biannually, the Board will review the Fund's annual and longer term strategic business plans and management development and succession plan.</p>
<p style="margin:6pt 0pt 0pt 0pt;">13.&#xa0;&#xa0;Board Compensation</p>
<p style="margin:6pt 0pt 0pt 0pt;">The Independent Trustees will establish and periodically review their compensation.</p>
<p style="margin:6pt 0pt 0pt 0pt;">14.&#xa0;&#xa0;Insurance Coverage and Indemnification</p>
<p style="margin:6pt 0pt 0pt 0pt;">The Fund will maintain directors' and officers'/errors and omissions insurance coverage and/or indemnification that is adequate to ensure the independence and effectiveness of the Independent Trustees. The Independent Trustees will periodically review the effectiveness of such insurance coverage and/or indemnification.</p>
<p style="margin:6pt 0pt 0pt 0pt;">15.&#xa0;&#xa0;Board Evaluation</p>
<p style="margin:6pt 0pt 0pt 0pt;">The Governance and Nominating Committee shall prepare a Board self-evaluation instrument that each trustee shall complete annually.</p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>23</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><b>Appendix B</b></p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: center;"><b>Procedures and Eligibility Requirements for<br>Shareholder Submission of Nominee Candidates</b><sup>1</sup></p>
<p style="margin:6pt 0pt 0pt 0pt;">A.&#xa0;&#xa0;Nominee Requirements</p>
<p style="margin:6pt 0pt 0pt 0pt;">Trustee nominees recommended by shareholders must fulfill the following requirements:</p>
<p style="margin:6pt 0pt 0pt 0pt;">1.&#xa0;&#xa0;The nominee may not be the nominating shareholder, a member of the nominating shareholder group, or a member of the immediate family of the nominating shareholder or any member of the nominating shareholder group.</p>
<p style="margin:6pt 0pt 0pt 0pt;">2.&#xa0;&#xa0;Neither the nominee nor any member of the nominee's immediate family may be currently employed or employed within the last year by any nominating shareholder entity or entity in a nominating shareholder group.</p>
<p style="margin:6pt 0pt 0pt 0pt;">3.&#xa0;&#xa0;Neither the nominee nor any immediate family member of the nominee is permitted to have accepted directly or indirectly, during the year of the election for which the nominee's name was submitted, during the immediately preceding calendar year, or during the year when the nominee's name was submitted, any consulting, advisory, or other compensatory fee from the nominating shareholder or any member of a nominating shareholder group.</p>
<p style="margin:6pt 0pt 0pt 0pt;">4.&#xa0;&#xa0;The nominee may not be an executive officer, director (or person performing similar functions) of the nominating shareholder or any member of the nominating shareholder group, or of an affiliate of the nominating shareholder or any such member of the nominating shareholder group.</p>
<p style="margin:6pt 0pt 0pt 0pt;">5.&#xa0;&#xa0;The nominee may not control (as "control" is defined in the 1940 Act) the nominating shareholder or any member of the nominating shareholder group (or in the case of a holder or member that is a fund, an interested person of such holder or member as defined by Section 2(a)(19) of the 1940 Act).</p>
<p style="margin:6pt 0pt 0pt 0pt;">B.&#xa0;&#xa0;Nominating Shareholder or Shareholder Group Requirements</p>
<p style="margin:6pt 0pt 0pt 0pt;">The nominating shareholder or shareholder group must meet the following requirements:</p>
<p style="margin:6pt 0pt 0pt 0pt;">1.&#xa0;&#xa0;Any shareholder or shareholder group submitting a proposed nominee must beneficially own, either individually or in the aggregate, more than 5% of the Fund's securities that are eligible to vote at the time of submission of the nominee and at the time of the meeting where the nominee may be elected. Each of the securities used for purposes of calculating the required ownership must have been held continuously for at least two years as of the date of the nomination. In addition, such securities must continue to be held through the date of the meeting. The nominating shareholder or shareholder group must also bear the economic risk of the investment, and the securities used for purposes of calculating the required ownership cannot be held "short."</p>
<p style="margin:6pt 0pt 0pt 0pt;">2.&#xa0;&#xa0;The nominating shareholder or shareholder group must also submit a certification which provides the number of shares which the person or group has (i) sole power to vote or direct the vote; (ii) shared power to vote or direct the vote; (iii) sole power to dispose or direct the disposition of such shares; and (iv) shared power to dispose or direct the disposition of such shares. In addition, the certification shall provide that the shares have been held continuously for at least 2 years.</p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font style="font-size: 8pt;"><sup>1</sup>&#xa0;&#xa0;Appendix B applies only to trustee nominee recommendations made by shareholders to the Governance and Nominating Committee. Refer to the Fund's By-laws regarding submission of shareholder proposals for the election of trustees. Unless otherwise specified herein, please refer to the Securities Exchange Act of 1934 and regulations thereunder for interpretations of terms used in this Appendix B.</font></p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>24</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;">C.&#xa0;&#xa0;Deadlines and Limitations</p>
<p style="margin:6pt 0pt 0pt 0pt;">1.&#xa0;&#xa0;A nominating shareholder or shareholder group may not submit more than one nominee per year.</p>
<p style="margin:6pt 0pt 0pt 0pt;">2.&#xa0;&#xa0;All nominee submissions must be received by the Fund by the deadline for submission of any shareholder proposals which would be included in the Fund's proxy statement for the next annual meeting of the Fund.</p>
<p style="margin:6pt 0pt 0pt 0pt;">D.&#xa0;&#xa0;Making a Submission</p>
<p style="margin:6pt 0pt 0pt 0pt;">Shareholders recommending potential trustee candidates must substantiate compliance with these requirements at the time of submitting their proposed trustee candidate to the attention of the Fund's Secretary. Notice to the Fund's Secretary should include: (i) the shareholder's contact information; (ii) the trustee candidate's contact information and the number of Fund shares owned by the proposed candidate; (iii) all information regarding the candidate that would be required to be disclosed in solicitations of proxies for elections of trustees required by Regulation 14A of the 1934 Act; and (iv) a notarized letter executed by the trustee candidate, stating his or her intention to stand for election and be named in the Fund's proxy statement, if nominated by the Board, and to serve as a trustee, if so elected.</p>
</div><div style="margin:8pt 0pt 8pt 0pt;">
 &#xa0;</div><p style="text-align: center;"><br>25</p><hr style="height: 3px; width: 100%; color: gray; background-color: gray; text-align: center;"><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#xa0;</p></div><p style="font-family: Times New Roman, Times, Serif; margin: 0">&#xa0;</p>

<p style="font: bold 14pt Times New Roman, Times, Serif;  margin: 0; text-align: center">EVERY SHAREHOLDER&#x2019;S VOTE IS IMPORTANT</p>

<p style="font: bold 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center">&#xa0;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center">&#xa0;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 14pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 68%"></td><td style="text-align: justify; width: 32%">EASY VOTING OPTIONS:</td>
</tr></table>

<p style="font: bold 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; font-family: Times New Roman, Times, Serif">
<tr>
    <td style="width: 68%">&#xa0;</td>
    <td style="width: 10%"><img alt="" src="tm222535d1_def14aimg001.jpg"></td>
    <td style="width: 22%">
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>VOTE ON THE INTERNET</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>Log on to:</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="color: Blue"><b><font style="text-decoration:underline">www.proxy-direct.com</font></b></font></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>or scan the QR code</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>Follow the on-screen instructions</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b><i>available 24 hours</i></b></p></td></tr>
</table>

<p style="font: bold 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; font-family: Times New Roman, Times, Serif">
  <tr>
    <td style="width: 68%">&#xa0;</td>
    <td style="width: 10%"><img alt="" src="tm222535d1_def14aimg002.gif" style="height: 80px; width: 60px"></td>
    <td style="width: 22%">
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>VOTE BY PHONE</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>Call 1-800-337-3503</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>Follow the recorded instructions</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b><i>available 24 hours</i></b></p></td></tr>
  </table>
<p style="margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; font-family: Times New Roman, Times, Serif">
  <tr>
    <td style="width: 68%">&#xa0;</td>
    <td style="width: 10%"><img alt="" src="tm222535d1_def14aimg003.gif" style="height: 37px; width: 58px"></td>
    <td style="width: 22%">
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>VOTE BY MAIL</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>Vote, sign and date this Proxy </b></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>Card and return in the </b></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>postage-paid envelope</b></p></td></tr>
  </table>
<p style="margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; font-family: Times New Roman, Times, Serif">
<tr>
    <td style="width: 68%">&#xa0;</td>
    <td style="width: 10%"><img alt="" src="tm222535d1_def14aimg004.jpg" style="height: 42.4pt; width: 46.1pt"></td>
    <td style="width: 22%">
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>VOTE IN PERSON</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>Attend Shareholder Meeting</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>100 Federal Street, 19<sup>th</sup> Floor</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>Boston, MA 02110</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>on June 9, 2022</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>at 4:30 P.M. Eastern Time</b></p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center">&#xa0;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center">Please detach at perforation before mailing.</p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>&#xa0;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>&#xa0;</b></p>

<table cellpadding="0" cellspacing="0" style="font: italic bold 10pt Times New Roman, Times, Serif;  margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 10%; text-align: left"><font style="font-style: normal">PROXY</font></td><td style="text-align: center; width: 80%"><font style="font-style: normal">TEKLA HEALTHCARE INVESTORS</font></td>
                                                                                                                          <td style="text-align: justify; width: 10%">&#xa0;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>JOINT ANNUAL MEETING OF SHAREHOLDERS </b></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>TO BE HELD JUNE 9, 2022</b></p>

<p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>&#xa0;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: justify"><b>This Proxy is Being Solicited on Behalf of the Board
of Trustees. </b>The undersigned hereby appoints Jeffrey A. Bailey, Thomas M. Kent, CPA and Daniel R. Omstead, Ph.D. and each of them,
proxies of the undersigned, with full powers of substitution, to vote at the Joint Annual Meeting of Shareholders of TEKLA HEALTHCARE
INVESTORS (the &#x201c;Fund&#x201d;) to be held on June 9, 2022 at 4:30 p.m. at 100 Federal Street, 19<sup>th</sup> Floor, Boston, Massachusetts
02110, and at any adjournment(s) or postponement(s) thereof, all the shares of the Fund outstanding in the name of the undersigned as
follows on the reverse of this card. Due to COVID-19 and the related recommendations, protocols and orders issued by public health authorities
and federal, state, and local governments, the date, time, location and/or means of conducting the Joint Annual Meeting may change. The
Funds plan to announce these changes, if any, at <font style="color: Blue"><font style="text-decoration:underline">www.teklacap.com</font></font> and encourage you to check
this website prior to the Joint Annual Meeting if you plan to attend.</p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: justify">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: justify"><b>THIS PROXY WILL BE VOTED AS SPECIFIED. IF NO SPECIFICATION
IS MADE, THIS PROXY WILL BE VOTED FOR ALL PROPOSALS.</b></p>

<p style="font: 8pt Times New Roman, Times, Serif;  margin: 0 0 0 4.5in"><b>&#xa0;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif;  margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 60%"></td><td style="padding-bottom: 3pt; text-align: justify; width: 40%"><b>VOTE VIA THE INTERNET: www.proxy-direct.com</b></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: bold 8pt Times New Roman, Times, Serif;  margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="padding-bottom: 3pt; width: 60%"></td><td style="padding-bottom: 3pt; text-align: justify; width: 40%">VOTE VIA THE TELEPHONE: 1-800-337-3503</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font-size: 14pt; vertical-align: top; text-align: justify">
<td style="font-size: 14pt; width: 60%"></td><td style="font-size: 14pt; background-color: rgb(216,216,216); border: Black 1pt solid; width: 20%; text-align: left">&#xa0;</td>
                            <td style="font-size: 14pt; width: 5%; text-align: left">&#xa0;</td><td style="font-size: 14pt; border: Black 1pt solid; text-align: justify; width: 15%"></td>
</tr></table>

<p style="font: 9pt Times New Roman, Times, Serif;  margin: 0 0 0 4.5in">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: center">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif;  margin: 0"><b>&#xa0;</b></p>

<p style="font: 9pt Times New Roman, Times, Serif;  margin: 0"><b>&#xa0;</b></p>

<p style="font: 8pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">HQH_32606_033122</font></p>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin: 0 0 3; text-align: center">PLEASE MARK, SIGN, DATE ON THE REVERSE SIDE AND
RETURN THIS PROXY PROMPTLY USING THE ENCLOSED ENVELOPE.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="padding-right: 5pt; text-align: justify; width: 11%">xxxxxxxxxxxxxx</td>
                            <td style="border: Black 1pt solid; padding-right: 5; text-align: center; padding-bottom: 3; padding-left: 5; width: 5%">code</td>
                            <td style="text-align: justify; width: 84%">&#xa0;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#xa0;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center">&#xa0;</p>

<p style="font: bold 14pt Times New Roman, Times, Serif;  margin: 0; text-align: center">EVERY SHAREHOLDER&#x2019;S VOTE IS IMPORTANT</p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>Important Notice Regarding the Availability of Proxy
Materials for the </b></p>

<p style="font: 12pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>Joint Annual Shareholder Meeting to Be Held on June
9, 2022.</b></p>

<p style="font: bold 12pt Times New Roman, Times, Serif;  margin: 0; text-align: center">The Joint Proxy Statement and Proxy Card for this
meeting are available at:</p>

<p style="font: bold 12pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="color: Blue"><font style="text-decoration:underline">https://www.proxy-direct.com/tkl-32606</font></font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal"></font>&#xa0;</p>

<p style="font: bold 12pt Times New Roman, Times, Serif;  margin: 0; text-align: center">IF YOU VOTE ON THE INTERNET OR BY TELEPHONE,</p>

<p style="font: bold 12pt Times New Roman, Times, Serif;  margin: 0; text-align: center">YOU NEED NOT RETURN THIS PROXY CARD</p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal"></font>&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: bold 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center">Please detach at perforation before mailing.</p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>&#xa0;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif;  margin: 0; text-align: center"><b>&#xa0;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif;  margin: 0"><font style="font-size: 8pt"><b>TO VOTE MARK BLOCKS BELOW IN BLUE OR BLACK
INK AS SHOWN IN THIS EXAMPLE: </b></font><b><font style=" font-size: 11pt">&#x2612;</font></b></p>

<p style="font: 9pt Times New Roman, Times, Serif;  margin: 0; text-align: justify"><b>&#xa0;</b></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif;  margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="background-color: Black; width: 3%; text-align: center"><font style="color: white">A</font></td>
                                                                                                                                           <td style="text-align: justify; width: 10%">&#xa0;&#xa0;&#xa0;Proposals</td>
                                                                                                                <td style="text-align: justify; width: 87%">The Board of Trustees recommends a vote FOR all the nominees listed and FOR Proposal 2.</td>
</tr></table>

<p style="font: bold 4 Times New Roman, Times, Serif;  margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td rowspan="2" style="text-align: center"><font style="font-size: 9pt"><b>1.</b></font></td>
    <td colspan="6" rowspan="2" style="text-align: left"><font style="font-size: 9pt">&#xa0;&#xa0;&#xa0;<font style="color: #231F20"><b>The
    election of three Class C Trustees:</b></font></font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">FOR</font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">WITHHOLD </font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">FOR ALL</font></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">ALL </font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">ALL </font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">EXCEPT</font></td></tr>
  <tr>
    <td style="vertical-align: top; width: 3%; text-align: center">&#xa0;</td>
    <td style="width: 4%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#xa0;&#xa0;&#xa0;01.</font></td>
    <td style="width: 22%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Kathleen L. Goetz</font></td>
    <td style="width: 3%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">02.</font></td>
    <td style="width: 22%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Oleg M. Pohotsky</font></td>
    <td style="width: 3%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">03.</font></td>
    <td style="width: 22%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">W. Mark Watson, CPA</font></td>
    <td style="vertical-align: top; width: 7%; text-align: center"><font>&#x2610;</font></td>
    <td style="vertical-align: top; width: 7%; text-align: center"><font>&#x2610;</font></td>
    <td style="vertical-align: top; width: 7%; text-align: center"><font>&#x2610;</font></td></tr>
  </table>

<p style="font: bold 4 Times New Roman, Times, Serif; margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif;  margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 3%; text-align: left"></td><td style="text-align: justify; width: 97%">&#xa0;&#xa0;&#xa0;<b><font style="text-decoration:underline">INSTRUCTIONS:</font></b> To withhold authority to vote for
any individual nominee(s), mark the box</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif;  margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 3%"></td><td style="text-align: justify; width: 97%">&#xa0;&#xa0;&#xa0;&#x201c;FOR ALL EXCEPT&#x201d; and write the nominee&#x2019;s number
on the line provided below.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif;  margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font-size: 10pt; vertical-align: top; text-align: justify">
<td style="font-size: 10pt; width: 3%"></td><td style="font-size: 10pt; padding-right: 30; padding-left: 10; text-align: justify; width: 60%"><p style="border-bottom: Black 1pt solid; font-size: 10pt; margin-top: 0; margin-bottom: 0">&#xa0;</p>
                                                                    <p style="font-size: 10pt; margin-top: 0; margin-bottom: 0">&#xa0;</p></td><td style="font-size: 10pt; text-align: justify; width: 37%">&#xa0;</td>
</tr></table>

<p style="font: 4pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif;  width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td rowspan="2" style="padding-top: 8; width: 3%; text-align: center"><font style="font-size: 9pt"><b>2.</b></font></td>
    <td rowspan="2" style="padding-top: 8; padding-right: 30; padding-left: 10; text-align: justify; width: 76%"><font style="font-size: 9pt">The ratification or rejection of the selection
    of Deloitte &amp; Touche LLP as the independent registered public accountants of the Fund for the fiscal year ending September 30,
    2022.</font></td>
    <td style="vertical-align: bottom; width: 7%; text-align: center"><font style="font-family: Times New Roman, Times, Serif;  font-size: 6pt">FOR</font></td>
    <td style="vertical-align: bottom; width: 7%; text-align: center"><font style="font-family: Times New Roman, Times, Serif;  font-size: 6pt">AGAINST </font></td>
    <td style="vertical-align: bottom; width: 7%; text-align: center"><font style="font-family: Times New Roman, Times, Serif;  font-size: 6pt">ABSTAIN</font></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><font>&#x2610;</font></td>
    <td style="text-align: center"><font>&#x2610;</font></td>
    <td style="text-align: center"><font>&#x2610;</font></td></tr>
  </table>
<p style="font: bold 4 Times New Roman, Times, Serif;  margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 9pt Times New Roman, Times, Serif;  margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="text-align: center; width: 3%"><b>3.</b></td><td style="padding-right: 30; padding-left: 10; text-align: justify; width: 76%">The transaction of such other business as may properly come before the Annual Meeting and any adjournment(s) or postponement(s) thereof.</td>
                                                                  <td style="padding-left: 10; text-align: justify; width: 21%">&#xa0;</td></tr></table>

<p style="font: 8pt Times New Roman, Times, Serif;  margin: 0 99.35pt 0 0.25in; text-align: justify; text-indent: -0.25in">&#xa0;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0 99.35pt 0 0.25in; text-align: justify; text-indent: -0.25in">&#xa0;</p>

<p style="font: 8pt Times New Roman, Times, Serif;  margin: 0 99pt 0 0.25in; text-align: justify; text-indent: -0.25in">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif;  margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="vertical-align: middle; background-color: Black; width: 3%; text-align: center"><font style="font-size: 9pt; color: white"><b>B</b></font></td><td style="text-align: justify; width: 97%">&#xa0;&#xa0;<font style="font-size: 10pt"><b>Authorized Signatures &#x2500;
This section must be completed for your vote to be counted. &#x2500; Sign and Date Below</b></font></td>
</tr></table>

<p style="font: 4 Times New Roman, Times, Serif;  margin-top: 0; margin-bottom: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif;  margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify; width: 3%"><font style="font-size: 8pt"><b>Note</b>: </font></td>
<td style="padding-left: 5pt; text-align: justify; width: 97%"><font style="font-size: 8pt">Please sign exactly as your name(s) appear(s) on this Proxy Card, and date it. When shares are held jointly,
each holder should sign. When signing as attorney, executor, guardian, administrator, trustee, officer of corporation or other entity
or in another representative capacity, please give the full title under the signature</font><font style="font-size: 7pt">.</font></td>
</tr></table>

<p style="font: 4 Times New Roman, Times, Serif;  margin: 0"><b>&#xa0;</b></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt Times New Roman, Times, Serif;  border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 32%"><font style="font-family: Times New Roman, Times, Serif;  font-size: 8pt"><b>Date (mm/dd/yyyy) &#x2500; Please print date below</b></font></td>
    <td style="width: 2%">&#xa0;</td>
    <td style="width: 32%"><font style="font-family: Times New Roman, Times, Serif;  font-size: 8pt"><b>Signature 1 &#x2500; Please keep signature within the box</b></font></td>
    <td style="width: 2%">&#xa0;</td>
    <td style="width: 32%"><font style="font-family: Times New Roman, Times, Serif;  font-size: 8pt"><b>Signature
    2 &#x2500; Please keep signature within the box</b></font></td></tr>
  <tr style="vertical-align: top">
    <td style="border: Black 1pt solid; padding: 3; text-align: center"><font style="font-size: 22"><b>/&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;/</b></font></td>
    <td style="padding: 3"><font style="font-size: 22">&#xa0;</font></td>
    <td style="border: Black 1pt solid; padding: 3"><font style="font-size: 22">&#xa0;</font></td>
    <td style="padding: 3"><font style="font-size: 22">&#xa0;</font></td>
    <td style="border: Black 1pt solid; padding: 3"><font style="font-size: 22">&#xa0;</font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif;  margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif;  margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="padding-top: 3; border: Black 1pt solid; text-align: center; padding-bottom: 3">Scanner bar code</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif; ">
  <tr style="vertical-align: top">
    <td style="text-align: center; width: 34%; font-size: 11pt"><font style="font-family: Times New Roman, Times, Serif;  font-size: 14pt">xxxxxxxxxxxxxx </font></td>
    <td style="text-align: center; width: 33%; font-size: 11pt"><font style="font-family: Times New Roman, Times, Serif;  font-size: 14pt">HQH 32606 </font></td>
    <td style="text-align: center; width: 33%; font-size: 11pt"><font style="font-family: Times New Roman, Times, Serif;  font-size: 14pt">xxxxxxxx</font></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#xa0;</p>

<p style="margin-top: 0; margin-bottom: 0">&#xa0;</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0; font-family: Times New Roman, Times, Serif">&#xa0;</p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">EVERY SHAREHOLDER&#x2019;S VOTE IS IMPORTANT</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 14pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 68%"></td><td style="text-align: justify; width: 32%">EASY VOTING OPTIONS:</td>
</tr></table>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; font-family: Times New Roman, Times, Serif">
<tr>
    <td style="width: 68%">&#xa0;</td>
    <td style="width: 10%"><img alt="" src="tm222535d1_def14aimg001.jpg"></td>
    <td style="width: 22%">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>VOTE ON THE INTERNET</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Log on to:</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="color: Blue"><b><font style="text-decoration:underline">www.proxy-direct.com</font></b></font></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>or scan the QR code</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Follow the on-screen instructions</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><i>available 24 hours</i></b></p></td></tr>
</table>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; font-family: Times New Roman, Times, Serif">
  <tr>
    <td style="width: 68%">&#xa0;</td>
    <td style="width: 10%"><img alt="" src="tm222535d1_def14aimg002.gif" style="height: 80px; width: 60px"></td>
    <td style="width: 22%">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>VOTE BY PHONE</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Call 1-800-337-3503</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Follow the recorded instructions</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><i>available 24 hours</i></b></p></td></tr>
  </table>
<p style="margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; font-family: Times New Roman, Times, Serif">
  <tr>
    <td style="width: 68%">&#xa0;</td>
    <td style="width: 10%"><img alt="" src="tm222535d1_def14aimg003.gif" style="height: 37px; width: 58px"></td>
    <td style="width: 22%">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>VOTE BY MAIL</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Vote, sign and date this Proxy </b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Card and return in the </b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>postage-paid envelope</b></p></td></tr>
  </table>
<p style="margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; font-family: Times New Roman, Times, Serif">
<tr>
    <td style="width: 68%">&#xa0;</td>
    <td style="width: 10%"><img alt="" src="tm222535d1_def14aimg004.jpg" style="height: 42.4pt; width: 46.1pt"></td>
    <td style="width: 22%">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>VOTE IN PERSON</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Attend Shareholder Meeting</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>100 Federal Street, 19<sup>th</sup> Floor</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Boston, MA 02110</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>on June 9, 2022</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>at 4:30 P.M. Eastern Time&#xa0;</b></p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Please detach at perforation before mailing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#xa0;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#xa0;</b></p>

<table cellpadding="0" cellspacing="0" style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 10%; text-align: left"><font style="font-style: normal">PROXY</font></td><td style="text-align: center; width: 80%"><font style="font-style: normal">TEKLA
HEALTHCARE OPPORTUNITIES FUND</font></td>
                                                                                                                          <td style="text-align: justify; width: 10%">&#xa0;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>JOINT ANNUAL MEETING OF SHAREHOLDERS </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>TO BE HELD JUNE 9, 2022</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#xa0;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>This Proxy is Being Solicited on Behalf of the
Board of Trustees. </b>The undersigned hereby appoints Jeffrey A. Bailey, Thomas M. Kent, CPA and Daniel R. Omstead, Ph.D. and each of
them, proxies of the undersigned, with full powers of substitution, to vote at the Joint Annual Meeting of Shareholders of TEKLA HEALTHCARE
OPPORTUNITIES FUND (the &#x201c;Fund&#x201d;) to be held on June 9, 2022 at 4:30 p.m. at 100 Federal Street, 19th Floor, Boston, Massachusetts
02110, and at any adjournment(s) or postponement(s) thereof, all the shares of the Fund outstanding in the name of the undersigned as
follows on the reverse of this card. Due to COVID-19 and the related recommendations, protocols and orders issued by public health authorities
and federal, state, and local governments, the date, time, location and/or means of conducting the Joint Annual Meeting may change. The
Funds plan to announce these changes, if any, at <font style="color: Blue"><font style="text-decoration:underline">www.teklacap.com</font></font> and encourage you to check
this website prior to the Joint Annual Meeting if you plan to attend.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>THIS PROXY WILL BE VOTED AS SPECIFIED. IF NO SPECIFICATION
IS MADE, THIS PROXY WILL BE VOTED FOR ALL PROPOSALS.</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 4.5in"><b>&#xa0;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 60%"></td><td style="padding-bottom: 3pt; text-align: justify; width: 40%"><b>VOTE VIA THE INTERNET: www.proxy-direct.com</b></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="padding-bottom: 3pt; width: 60%"></td><td style="padding-bottom: 3pt; text-align: justify; width: 40%">VOTE VIA THE TELEPHONE: 1-800-337-3503</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font-size: 14pt; vertical-align: top; text-align: justify">
<td style="font-size: 14pt; width: 60%"></td><td style="border: Black 1pt solid; font-size: 14pt; background-color: rgb(216,216,216); width: 20%; text-align: left">&#xa0;</td>
                            <td style="font-size: 14pt; width: 5%; text-align: left">&#xa0;</td><td style="border: Black 1pt solid; font-size: 14pt; text-align: justify; width: 15%"></td>
</tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 4.5in">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>&#xa0;</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>&#xa0;</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">THQ_32083_033122</font></p>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin: 0 0 3; text-align: center">PLEASE MARK, SIGN, DATE ON THE REVERSE SIDE AND
RETURN THIS PROXY PROMPTLY USING THE ENCLOSED ENVELOPE.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="padding-right: 5pt; text-align: justify; width: 11%">xxxxxxxxxxxxxx</td>
                            <td style="border: Black 1pt solid; padding-right: 5; text-align: center; padding-bottom: 3; padding-left: 5; width: 5%">code</td>
                            <td style="text-align: justify; width: 84%">&#xa0;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#xa0;</p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#xa0;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">EVERY SHAREHOLDER&#x2019;S VOTE IS IMPORTANT</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Important Notice Regarding the Availability of Proxy
Materials for the </b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Joint Annual Shareholder Meeting to Be Held on June
9, 2022.</b></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">The Joint Proxy Statement and Proxy Card for this
meeting are available at:</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="color: Blue"><font style="text-decoration:underline">https://www.proxy-direct.com/tkl-32606</font></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal"></font>&#xa0;</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">IF YOU VOTE ON THE INTERNET OR BY TELEPHONE,</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">YOU NEED NOT RETURN THIS PROXY CARD</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal"></font>&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Please detach at perforation before mailing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#xa0;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#xa0;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt"><b>TO VOTE MARK BLOCKS BELOW IN BLUE OR BLACK
INK AS SHOWN IN THIS EXAMPLE: </b></font><b><font style=" font-size: 11pt">&#x2612;</font></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#xa0;</b></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="background-color: Black; width: 3%; text-align: center"><font style="color: white">A</font></td>
                                                                                                                                           <td style="text-align: justify; width: 10%">&#xa0;&#xa0;&#xa0;Proposals</td>
                                                                                                                <td style="text-align: justify; width: 87%">The Board of Trustees recommends a vote FOR all the nominees listed and FOR Proposal 2.</td>
</tr></table>

<p style="font: bold 4 Times New Roman, Times, Serif; margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td rowspan="2" style="text-align: center"><font style="font-size: 9pt"><b>1.</b></font></td>
    <td colspan="6" rowspan="2" style="text-align: left"><font style="font-size: 9pt">&#xa0;&#xa0;&#xa0;<font style="color: #231F20"><b>The
    election of two Class B  Trustees:</b></font></font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">FOR</font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">WITHHOLD </font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">FOR ALL</font></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">ALL </font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">ALL </font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">EXCEPT</font></td></tr>
  <tr>
    <td style="vertical-align: top; width: 3%; text-align: center">&#xa0;</td>
    <td style="width: 4%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#xa0;&#xa0;&#xa0;01.</font></td>
    <td style="width: 22%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Rakesh K. Jain, Ph.D.</font></td>
    <td style="width: 3%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">02.</font></td>
    <td style="width: 22%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Daniel R. Omstead, Ph.D.</font></td>
    <td style="width: 3%">&#xa0;</td>
    <td style="width: 22%">&#xa0;</td>
    <td style="vertical-align: top; width: 7%; text-align: center"><font>&#x2610;</font></td>
    <td style="vertical-align: top; width: 7%; text-align: center"><font>&#x2610;</font></td>
    <td style="vertical-align: top; width: 7%; text-align: center"><font>&#x2610;</font></td></tr>
  </table>

<p style="font: bold 4 Times New Roman, Times, Serif; margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 3%; text-align: left"></td><td style="text-align: justify; width: 97%">&#xa0;&#xa0;&#xa0;<b><font style="text-decoration:underline">INSTRUCTIONS:</font></b> To withhold authority to vote for
any individual nominee(s), mark the box</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 3%"></td><td style="text-align: justify; width: 97%">&#xa0;&#xa0;&#xa0;&#x201c;FOR ALL EXCEPT&#x201d; and write the nominee&#x2019;s number
on the line provided below.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font-size: 10pt; vertical-align: top; text-align: justify">
<td style="font-size: 10pt; width: 3%"></td><td style="font-size: 10pt; padding-right: 30; padding-left: 10; text-align: justify; width: 60%"><p style="border-bottom: Black 1pt solid; font-size: 10pt; margin-top: 0; margin-bottom: 0">&#xa0;</p>
                                                                    <p style="font-size: 10pt; margin-top: 0; margin-bottom: 0">&#xa0;</p></td><td style="font-size: 10pt; text-align: justify; width: 37%">&#xa0;</td>
</tr></table>

<p style="font: 4pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td rowspan="2" style="padding-top: 8; width: 3%; text-align: center"><font style="font-size: 9pt"><b>2.</b></font></td>
    <td rowspan="2" style="padding-top: 8; padding-right: 30; padding-left: 10; text-align: justify; width: 76%"><font style="font-size: 9pt">The ratification or rejection of the selection
    of Deloitte &amp; Touche LLP as the independent registered public accountants of the Fund for the fiscal year ending September 30,
    2022.</font></td>
    <td style="vertical-align: bottom; width: 7%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">FOR</font></td>
    <td style="vertical-align: bottom; width: 7%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">AGAINST </font></td>
    <td style="vertical-align: bottom; width: 7%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">ABSTAIN</font></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><font>&#x2610;</font></td>
    <td style="text-align: center"><font>&#x2610;</font></td>
    <td style="text-align: center"><font>&#x2610;</font></td></tr>
  </table>
<p style="font: bold 4 Times New Roman, Times, Serif; margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="text-align: center; width: 3%"><b>3.</b></td><td style="padding-right: 30; padding-left: 10; text-align: justify; width: 76%">The transaction of such other business as may properly come before the Annual Meeting and any adjournment(s) or postponement(s) thereof.</td>
                                                                  <td style="padding-left: 10; text-align: justify; width: 21%">&#xa0;</td></tr></table>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0 99.35pt 0 0.25in; text-align: justify; text-indent: -0.25in">&#xa0;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0 99.35pt 0 0.25in; text-align: justify; text-indent: -0.25in">&#xa0;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0 99pt 0 0.25in; text-align: justify; text-indent: -0.25in">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="vertical-align: middle; background-color: Black; width: 3%; text-align: center"><font style="font-size: 9pt; color: white"><b>B</b></font></td><td style="text-align: justify; width: 97%">&#xa0;&#xa0;<font style="font-size: 10pt"><b>Authorized Signatures &#x2500;
This section must be completed for your vote to be counted. &#x2500; Sign and Date Below</b></font></td>
</tr></table>

<p style="font: 4 Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify; width: 3%"><font style="font-size: 8pt"><b>Note</b>: </font></td>
<td style="padding-left: 5pt; text-align: justify; width: 97%"><font style="font-size: 8pt">Please sign exactly as your name(s) appear(s) on this Proxy Card, and date it. When shares are held jointly,
each holder should sign. When signing as attorney, executor, guardian, administrator, trustee, officer of corporation or other entity
or in another representative capacity, please give the full title under the signature</font><font style="font-size: 7pt">.</font></td>
</tr></table>

<p style="font: 4 Times New Roman, Times, Serif; margin: 0"><b>&#xa0;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 32%"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Date (mm/dd/yyyy) &#x2500; Please print date below</b></font></td>
    <td style="width: 2%">&#xa0;</td>
    <td style="width: 32%"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Signature 1 &#x2500; Please keep signature within the box</b></font></td>
    <td style="width: 2%">&#xa0;</td>
    <td style="width: 32%"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Signature
    2 &#x2500; Please keep signature within the box</b></font></td></tr>
  <tr style="vertical-align: top">
    <td style="border: Black 1pt solid; padding: 3; text-align: center"><font style="font-size: 22"><b>/&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;/</b></font></td>
    <td style="padding: 3"><font style="font-size: 22">&#xa0;</font></td>
    <td style="border: Black 1pt solid; padding: 3"><font style="font-size: 22">&#xa0;</font></td>
    <td style="padding: 3"><font style="font-size: 22">&#xa0;</font></td>
    <td style="border: Black 1pt solid; padding: 3"><font style="font-size: 22">&#xa0;</font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="border: Black 1pt solid; padding-top: 3; text-align: center; padding-bottom: 3">Scanner bar code</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
  <tr style="vertical-align: top">
    <td style="text-align: center; width: 34%; font-size: 11pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 14pt">xxxxxxxxxxxxxx </font></td>
    <td style="text-align: center; width: 33%; font-size: 11pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 14pt">THQ 32606 </font></td>
    <td style="text-align: center; width: 33%; font-size: 11pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 14pt">xxxxxxxx</font></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#xa0;</p>

<p style="margin-top: 0; margin-bottom: 0">&#xa0;</p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#xa0;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0; font-family: Times New Roman, Times, Serif">&#xa0;</p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">EVERY SHAREHOLDER&#x2019;S VOTE IS IMPORTANT</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 14pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 68%"></td><td style="text-align: justify; width: 32%">EASY VOTING OPTIONS:</td>
</tr></table>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; font-family: Times New Roman, Times, Serif">
<tr>
    <td style="width: 68%">&#xa0;</td>
    <td style="width: 10%"><img alt="" src="tm222535d1_def14aimg001.jpg"></td>
    <td style="width: 22%">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>VOTE ON THE INTERNET</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Log on to:</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="color: Blue"><b><font style="text-decoration:underline">www.proxy-direct.com</font></b></font></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>or scan the QR code</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Follow the on-screen instructions</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><i>available 24 hours</i></b></p></td></tr>
</table>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; font-family: Times New Roman, Times, Serif">
  <tr>
    <td style="width: 68%">&#xa0;</td>
    <td style="width: 10%"><img alt="" src="tm222535d1_def14aimg002.gif" style="height: 80px; width: 60px"></td>
    <td style="width: 22%">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>VOTE BY PHONE</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Call 1-800-337-3503</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Follow the recorded instructions</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><i>available 24 hours</i></b></p></td></tr>
  </table>
<p style="margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; font-family: Times New Roman, Times, Serif">
  <tr>
    <td style="width: 68%">&#xa0;</td>
    <td style="width: 10%"><img alt="" src="tm222535d1_def14aimg003.gif" style="height: 37px; width: 58px"></td>
    <td style="width: 22%">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>VOTE BY MAIL</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Vote, sign and date this Proxy </b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Card and return in the </b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>postage-paid envelope</b></p></td></tr>
  </table>
<p style="margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; font-family: Times New Roman, Times, Serif">
<tr>
    <td style="width: 68%">&#xa0;</td>
    <td style="width: 10%"><img alt="" src="tm222535d1_def14aimg004.jpg" style="height: 42.4pt; width: 46.1pt"></td>
    <td style="width: 22%">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>VOTE IN PERSON</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Attend Shareholder Meeting</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>100 Federal Street, 19<sup>th</sup> Floor</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Boston, MA 02110</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>on June 9, 2022</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>at 4:30 P.M. Eastern Time&#xa0;</b></p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Please detach at perforation before mailing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#xa0;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#xa0;</b></p>

<table cellpadding="0" cellspacing="0" style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 10%; text-align: left"><font style="font-style: normal">PROXY</font></td><td style="text-align: center; width: 80%"><font style="font-style: normal">TEKLA
WORLD HEALTHCARE FUND</font></td>
                                                                                                                          <td style="text-align: justify; width: 10%">&#xa0;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>JOINT ANNUAL MEETING OF SHAREHOLDERS </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>TO BE HELD JUNE 9, 2022</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#xa0;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>This Proxy is Being Solicited on Behalf of the
Board of Trustees. </b>The undersigned hereby appoints Jeffrey A. Bailey, Thomas M. Kent, CPA and Daniel R. Omstead, Ph.D. and each of
them, proxies of the undersigned, with full powers of substitution, to vote at the Joint Annual Meeting of Shareholders of TEKLA WORLD
HEALTHCARE FUND (the &#x201c;Fund&#x201d;) to be held on June 9, 2022 at 4:30 p.m. at 100 Federal Street, 19th Floor, Boston, Massachusetts
02110, and at any adjournment(s) or postponement(s) thereof, all the shares of the Fund outstanding in the name of the undersigned as
follows on the reverse of this card. Due to COVID-19 and the related recommendations, protocols and orders issued by public health authorities
and federal, state, and local governments, the date, time, location and/or means of conducting the Joint Annual Meeting may change. The
Funds plan to announce these changes, if any, at <font style="color: Blue"><font style="text-decoration:underline">www.teklacap.com</font></font> and encourage you to check
this website prior to the Joint Annual Meeting if you plan to attend.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>THIS PROXY WILL BE VOTED AS SPECIFIED. IF NO SPECIFICATION
IS MADE, THIS PROXY WILL BE VOTED FOR ALL PROPOSALS.</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 4.5in"><b>&#xa0;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 60%"></td><td style="padding-bottom: 3pt; text-align: justify; width: 40%"><b>VOTE VIA THE INTERNET: www.proxy-direct.com</b></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="padding-bottom: 3pt; width: 60%"></td><td style="padding-bottom: 3pt; text-align: justify; width: 40%">VOTE VIA THE TELEPHONE: 1-800-337-3503</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font-size: 14pt; vertical-align: top; text-align: justify">
<td style="font-size: 14pt; width: 60%"></td><td style="border: Black 1pt solid; font-size: 14pt; background-color: rgb(216,216,216); width: 20%; text-align: left">&#xa0;</td>
                            <td style="font-size: 14pt; width: 5%; text-align: left">&#xa0;</td><td style="border: Black 1pt solid; font-size: 14pt; text-align: justify; width: 15%"></td>
</tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 0 4.5in">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>&#xa0;</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>&#xa0;</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">THW_32606_033122</font></p>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin: 0 0 3; text-align: center">PLEASE MARK, SIGN, DATE ON THE REVERSE SIDE AND
RETURN THIS PROXY PROMPTLY USING THE ENCLOSED ENVELOPE.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="padding-right: 5pt; text-align: justify; width: 11%">xxxxxxxxxxxxxx</td>
                            <td style="border: Black 1pt solid; padding-right: 5; text-align: center; padding-bottom: 3; padding-left: 5; width: 5%">code</td>
                            <td style="text-align: justify; width: 84%">&#xa0;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#xa0;</p>


<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#xa0;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#xa0;</p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">EVERY SHAREHOLDER&#x2019;S VOTE IS IMPORTANT</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Important Notice Regarding the Availability of Proxy
Materials for the </b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Joint Annual Shareholder Meeting to Be Held on June
9, 2022.</b></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">The Joint Proxy Statement and Proxy Card for this
meeting are available at:</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="color: Blue"><font style="text-decoration:underline">https://www.proxy-direct.com/tkl-32606</font></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal"></font>&#xa0;</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">IF YOU VOTE ON THE INTERNET OR BY TELEPHONE,</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">YOU NEED NOT RETURN THIS PROXY CARD</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal"></font>&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-weight: normal">&#xa0;</font></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Please detach at perforation before mailing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#xa0;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#xa0;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt"><b>TO VOTE MARK BLOCKS BELOW IN BLUE OR BLACK
INK AS SHOWN IN THIS EXAMPLE: </b></font><b><font style=" font-size: 11pt">&#x2612;</font></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#xa0;</b></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="background-color: Black; width: 3%; text-align: center"><font style="color: white">A</font></td>
                                                                                                                                           <td style="text-align: justify; width: 10%">&#xa0;&#xa0;&#xa0;Proposals</td>
                                                                                                                <td style="text-align: justify; width: 87%">The Board of Trustees recommends a vote FOR all the nominees listed and FOR Proposal 2.</td>
</tr></table>

<p style="font: bold 4 Times New Roman, Times, Serif; margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td rowspan="2" style="text-align: center"><font style="font-size: 9pt"><b>1.</b></font></td>
    <td colspan="6" rowspan="2" style="text-align: left"><font style="font-size: 9pt">&#xa0;&#xa0;&#xa0;<font style="color: #231F20"><b>The
    election of three Class A  Trustees:</b></font></font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">FOR</font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">WITHHOLD </font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">FOR ALL</font></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">ALL </font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">ALL </font></td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">EXCEPT</font></td></tr>
  <tr>
    <td style="vertical-align: top; width: 3%; text-align: center">&#xa0;</td>
    <td style="width: 4%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#xa0;&#xa0;&#xa0;01.</font></td>
    <td style="width: 22%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Kathleen L. Goetz</font></td>
    <td style="width: 3%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">02.</font></td>
    <td style="width: 22%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Oleg M. Pohotsky</font></td>
    <td style="width: 3%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">03.</font></td>
    <td style="width: 22%"><font style="font-family: Times New Roman, Times, Serif; font-size: 9pt">W. Mark Watson, CPA</font></td>
    <td style="vertical-align: top; width: 7%; text-align: center"><font>&#x2610;</font></td>
    <td style="vertical-align: top; width: 7%; text-align: center"><font>&#x2610;</font></td>
    <td style="vertical-align: top; width: 7%; text-align: center"><font>&#x2610;</font></td></tr>
  </table>

<p style="font: bold 4 Times New Roman, Times, Serif; margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 3%; text-align: left"></td><td style="text-align: justify; width: 97%">&#xa0;&#xa0;&#xa0;<b><font style="text-decoration:underline">INSTRUCTIONS:</font></b> To withhold authority to vote for
any individual nominee(s), mark the box</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 3%"></td><td style="text-align: justify; width: 97%">&#xa0;&#xa0;&#xa0;&#x201c;FOR ALL EXCEPT&#x201d; and write the nominee&#x2019;s number
on the line provided below.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font-size: 10pt; vertical-align: top; text-align: justify">
<td style="font-size: 10pt; width: 3%"></td><td style="font-size: 10pt; padding-right: 30; padding-left: 10; text-align: justify; width: 60%"><p style="border-bottom: Black 1pt solid; font-size: 10pt; margin-top: 0; margin-bottom: 0">&#xa0;</p>
                                                                    <p style="font-size: 10pt; margin-top: 0; margin-bottom: 0">&#xa0;</p></td><td style="font-size: 10pt; text-align: justify; width: 37%">&#xa0;</td>
</tr></table>

<p style="font: 4pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td rowspan="2" style="padding-top: 8; width: 3%; text-align: center"><font style="font-size: 9pt"><b>2.</b></font></td>
    <td rowspan="2" style="padding-top: 8; padding-right: 30; padding-left: 10; text-align: justify; width: 76%"><font style="font-size: 9pt">The ratification or rejection of the selection
    of Deloitte &amp; Touche LLP as the independent registered public accountants of the Fund for the fiscal year ending September 30,
    2022.</font></td>
    <td style="vertical-align: bottom; width: 7%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">FOR</font></td>
    <td style="vertical-align: bottom; width: 7%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">AGAINST </font></td>
    <td style="vertical-align: bottom; width: 7%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 6pt">ABSTAIN</font></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><font>&#x2610;</font></td>
    <td style="text-align: center"><font>&#x2610;</font></td>
    <td style="text-align: center"><font>&#x2610;</font></td></tr>
  </table>
<p style="font: bold 4 Times New Roman, Times, Serif; margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="text-align: center; width: 3%"><b>3.</b></td><td style="padding-right: 30; padding-left: 10; text-align: justify; width: 76%">The transaction of such other business as may properly come before the Annual Meeting and any adjournment(s) or postponement(s) thereof.</td>
                                                                  <td style="padding-left: 10; text-align: justify; width: 21%">&#xa0;</td></tr></table>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0 99.35pt 0 0.25in; text-align: justify; text-indent: -0.25in">&#xa0;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0 99.35pt 0 0.25in; text-align: justify; text-indent: -0.25in">&#xa0;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0 99pt 0 0.25in; text-align: justify; text-indent: -0.25in">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="vertical-align: middle; background-color: Black; width: 3%; text-align: center"><font style="font-size: 9pt; color: white"><b>B</b></font></td><td style="text-align: justify; width: 97%">&#xa0;&#xa0;<font style="font-size: 10pt"><b>Authorized Signatures &#x2500;
This section must be completed for your vote to be counted. &#x2500; Sign and Date Below</b></font></td>
</tr></table>

<p style="font: 4 Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify; width: 3%"><font style="font-size: 8pt"><b>Note</b>: </font></td>
<td style="padding-left: 5pt; text-align: justify; width: 97%"><font style="font-size: 8pt">Please sign exactly as your name(s) appear(s) on this Proxy Card, and date it. When shares are held jointly,
each holder should sign. When signing as attorney, executor, guardian, administrator, trustee, officer of corporation or other entity
or in another representative capacity, please give the full title under the signature</font><font style="font-size: 7pt">.</font></td>
</tr></table>

<p style="font: 4 Times New Roman, Times, Serif; margin: 0"><b>&#xa0;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 32%"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Date (mm/dd/yyyy) &#x2500; Please print date below</b></font></td>
    <td style="width: 2%">&#xa0;</td>
    <td style="width: 32%"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Signature 1 &#x2500; Please keep signature within the box</b></font></td>
    <td style="width: 2%">&#xa0;</td>
    <td style="width: 32%"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Signature
    2 &#x2500; Please keep signature within the box</b></font></td></tr>
  <tr style="vertical-align: top">
    <td style="border: Black 1pt solid; padding: 3; text-align: center"><font style="font-size: 22"><b>/&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;/</b></font></td>
    <td style="padding: 3"><font style="font-size: 22">&#xa0;</font></td>
    <td style="border: Black 1pt solid; padding: 3"><font style="font-size: 22">&#xa0;</font></td>
    <td style="padding: 3"><font style="font-size: 22">&#xa0;</font></td>
    <td style="border: Black 1pt solid; padding: 3"><font style="font-size: 22">&#xa0;</font></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="border: Black 1pt solid; padding-top: 3; text-align: center; padding-bottom: 3">Scanner bar code</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
  <tr style="vertical-align: top">
    <td style="text-align: center; width: 34%; font-size: 11pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 14pt">xxxxxxxxxxxxxx </font></td>
    <td style="text-align: center; width: 33%; font-size: 11pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 14pt">THW 32606 </font></td>
    <td style="text-align: center; width: 33%; font-size: 11pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 14pt">xxxxxxxx</font></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#xa0;</p>

<p style="margin-top: 0; margin-bottom: 0">&#xa0;</p>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#xa0;</p>






</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>j2225352_aa001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j2225352_aa001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ )P"Z P$1  (1 0,1 ?_$ :(    & @,!
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/-%:%IE/NO=#+[]U[K__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm222535d1_coverimg001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm222535d1_coverimg001.gif
M1TE&.#=A>  I '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MU4QE")1"&7P88L8#  1PR$Q8%8'-&0(98<@@:(0@$")3C@(!8%_DD<@8;T;
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MDC90![!65,-$OW-#1@OU_P' $[LMA$P& )2R$"< 9$",9YC6DQ,"/4.TT!,
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%$"4@ #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm222535d1_def14aimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm222535d1_def14aimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !- % # 2(  A$! Q$!_\0
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MQ'^'VA^-/#OCR&^T*Q\2_&[2?$?B5H?!\CW/ASX.^(+>TU6POTMM6T#]3/\
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M<\2FYUC3-1\2V5EJO@Z[N(H]&U/\P_BK\$?V6/V*/&?PU_:1_:7_ &)O'Z>
M_P!K_P"'/A34O W[(WB/5OAU\,/BA\!(_$'B'5O ]CJGC6T\?_LMZMHVH7FJ
M7?P#\9^/M,N-'^'GA%;_ ,.?%;PQ90W$LMGJOB/Q%_1;_P $V_V5_P!F'X+?
MLF_\%)?A9^TU8ZKJ6OWW_!7K]I_]AOX6_MP>-_AW!KW[65IXG^(MK\)OA)\.
MOBYH'Q=E\ ^*O$OA;Q=:^+=>U/Q5I7Q+<:;X,T[QPUWXGE\0:3!?23U^5_\
MP4?^/7[5OP[^%'[4W_!-GPE^S;X,_:L_90_8^M?A]INH_P#!23XY[O''[3FA
M^$_$/Q-^$?QE%U??%75/$5AI.K:IX>\8_'O2_ACHWAGPAX>&KVWA+5H$CTL+
M;:Y<H ?</[77_!'SP1\;?^">G[*VO> /VP_V8_V ?V)?C1IOP6_:%L?"'[3F
MMZ1X).F^._&WPBU3QAX1\'7'CG1;KX9?"77]0TVZ^*7QAO(KF'X=:?K%_!<6
M4^F6UG)<^*+J^]U_;2\3?##_ (+*ZE_P;M^)OBE\*_$7A+X<_M377_!0#Q3K
M?PTT27P]XUU[3I/ WP(N-3LH-'UOQ%X2NM"U+1Y/$'@FRUR">[\"W+3Z0]C)
M$MA>VL.H#]4_V0/V@?V'_'G[)W_!._\ 8S^-$/PJ^+?Q1O?V$/V:OBCH7PG^
M-?@J+6O!L!\'_LX_!&ZO-4T[4_B#X-O?AKINN6OA;XN:=>VD#>)(O$5Q8W.H
MVVFVER+/7X]._G=^'/QQ\*_LL?L=?\&P'[1?Q)C\17GPV^&.C_\ !0T>,+K1
MM)\5>*)M'L_$7@+Q7\-/"6HV]KX)\+^--<LM.UG5_$^D1E+;PYJD>;ZS2:[M
M+2WGO" ?D[\;/VG/^"/OP<_:4^+/[/EU_P $UOBEKT_PJ^-WC7X,7'B_3?C%
M^R_:6VJW'@GQQJ?@F;Q!'X?D_8CG?3([^327U*+2'UR[>U5S9-J,S1F[/]97
M_!!C]F3X8_LC?\%%_P#@KG\%/A#'<6_@;P[IW[/\&F6=V/#\=Q;+I/QT_;>\
M)VR2V_ACP_X9T>!QH_AG28G2WTJ$!X62/R[6.VMK?^=[XR?LJ?\ !N7\6_C_
M /%?X\:_^WI^V_H'BKXG?%7Q?\;;C1+#]G;XS:;X=OM?\;^*K_QUJWA;PKI>
MJ_L.RZO:Z?H.K:V/#UG<7.I:S<7$ M[L#_240_T=?\$+/VA/!_[4O_!0K_@K
M-\</AO)XEU'X<>(=-^ 5KX6UW7_"_CKPLNJ6L_QN_;8\76TD-AX]\+>$]:CN
M6T+Q;H-Y>02:3;RV8O8(;R&WN_,MH0#[.TS7?VN?VB/@[^T0?V.?^"KWPE\<
M_%'X:?M8?$.TU;Q1X6_8R^'_ (LB^'WA?PUX7U''[(FH^#M5^*=I:ZIXO\/^
M(=0T34;OXI37LOB6_4V^EMX=6.XFF?\ )C]BC_@IG_P4K_;P^$_[14?QM^/7
MA+_@DGXT_P""?'A_P@W[6?Q-^-/[-WA7XP:7\38?']AXO\/'6=9^'GC.[^"#
M_!%/ 7C;X&_%",:/H6N^+;O7]6^(T?ARYEMY/ 6FQ^(/PB^)_P"WE8?'O_@H
MI\>O!7[5FK:K^R1^R9X%^*GQ:^ ^D^)_V9_"&N:NWC7XN:#\<KG2?#5SXP\7
M?%WP'^UE)H_Q%U_X:ZCXVU#4_"FD:=X2\.VQ\/:9J<?A?3&%S!K7[]^-?!/[
M&7_!%6/]I;X??L]_&GQ%^U1^U+_P40UC3/#/C"+]H+Q5X7\1^!?AWXJ\)^-O
M$OARPG^,W_#-GP]^"'ACX->$[[6_CM\1+_Q%<_$WXG? RTNE\+ZU9Z'XS\.6
MWA37+K1 #\E="_X+%>/_ -G/_@I#\'_C#^WM^S!J7[27[55S%\//AS^SC^UA
M)XC\1_LB^$KG]FSQA=>.? 6L0Z7\ ]-^&OC;PGXPA\$?$'XK?M%:1>>.[_Q"
M;K6]7AF\/PG2[GP=;20_J!^TMX=_8@^'G_!RO^SSJ?B'1S^T-^U+^TOXL^'M
MMI6A:-\0O%?PVG_X)_3?"7X%Z18>&;[QWX0TRS\1P?'Z3]H'2M3E\7Z99:U>
M?# >!]&T2!8AKEMJ?]J/^"OPJ_9%\"?MO?"3XH?M5?$+]LWX!?##]N3X _M&
M>$O"/PC^$MG^T)^R3H/P'\2_#[PEX>_9S^)=EXCTRU\=?%%=<UZW^T>,_BJN
MN^(8?CYK>CCQ+H$NA0+I%UX:U/PC+^OWPB^"/A3_ (+-?M?>(V_X*,_%;X8?
MLN_M+_LQW_@#0OV8/%W[%GQ#^'6D>&?V@(_BWX0U'6O%T>A0?&KX@_MC?#KX
MX:Q\.E\):!X>OM-^!WB&&[\#W6OZC;_$JQ;6M2\/PZ. ?K/_ ,%"OB?\9_%G
M_!/7]M?P=\+?VO\ P3\<=%U?]MSQ9^S%^T!\3? O[/VG2V/[!/[(GB!/#_A+
M]HKP5\1O#6F>+-;?Q5JW[)OPTU;7/'/C7XM^(]4\,7UUIMW!?:U9:+9V NIO
MP*_8N\.?MZ?%/QY\+/\ @E1)JGC/]K/_ ((+>)[GQ)H^K?MF^ _V=XOAGX-\
M;^!(=)\2?'SQ%K.G_&C3H?$5KX>TCP1^TK:ZCX%U358O$UREUXA\*WW@Y]0M
M+F\;0;?]8O@Y^QU_P2M_X)2_')]0T7_@H1XN^,/Q)^,/[04_P7^('[.WBKXM
M_LY:YK"_%O\ :EU?3_@UXI\2^)_!'P<^"MI\9O#$\?\ :$&EZIIT6K>#O!WA
MR[U&2_N[KPK MO/:_+WP$^"W[84__!PU\7&^%NG^*?"7[!WP0\2OX_U&QNO!
M7AI?"6M^$?$'[/'PUU+4KC2?BIX]4>+[]M8\:_%RTUY;;0M7\1ZK:V\=Y8V=
MC#HVG:D^C 'X3?\ !??X&?LO_#^PTG4OAE_P5"^'G[4?BSX$_%BV_9K\ ?L@
M^&/A7X?\&^,O@'\&OAWX&F^%6FZ+XI^*UOXR\1_\+$UKX6:!\'/AI\./$/B/
M5O">G7OBG6TU#Q#/#IM_J5Q;I^_?[4/_  61^"__  3=_9V_8Y\.?\$;_%/A
M+]JS]CG]E^'XB>'/VK?"&@WFL^)+7P!X/\=)I^G?L]77Q ^,'B#PGXFUCX<)
MKGQ7\2>(3H-U=1&7QKJ6FKX8$J0,J#@OC)^S=\7/VHO^"B_QM_;,_P""<OP2
M^%OQ6U_X.^/?B]\%_B=H/Q9\2^(I?"FJ>)&U2T^#?B37ISJ/[0G[,^L:=>:/
MXY^ ?Q M--3P_?7OAO4AJ?GVQU/2(/#VJZM^2E[_ ,%!_BM^V]_P21_X*-_#
MWQQ^S]\)OV>O$EU?_L::]^SUX=^#FB_'&37_ (X7VF_M!ZF_Q'3PCHOQH^*O
MQ?U/XH67P[\,V]WJVOI\-(X9?#,.JRZWXENUTBVM+:( _7?Q3_P<B_M4>+?V
MD]1B_86^#FD_MG_!G6_V7-,^('B?X6_"/3M5U;Q!^RYXDU3X>_L\:OXI^)7C
MKQIIG@'Q)KWB#P]\(OB!XH^*7@W5M%\0>'?"FD:U>31-<ZA8#1K2"7],/^"&
MO[?OQR_:Y_:%_;J^&?Q&_:U^&/[:7PY^!FG_  9N?AK\8_AG\'?#GP6TJ_U#
MQYXW_: T#Q/-/HFA:WXC^VOXBT+X8> O%-O!-K%Q%I%MJT=I:1KYT]U>_FQ_
MP1+_ &4_VC?@1\??B;^U)\:O"7P:^&WQ$_X=2R^%M,_9Z\*:U;>)O'FH:;!X
M6_93U?P??^*?AU8_M)_$OXQV-U'X3^&7A)?$,5OX3\)"X\0_$6.T$7AJ_P!0
M\+>&T_5W_@@3^SAI6D_#+XI?MO>(?AWXD^#?QA_:\T_X1W_Q$^%-S:^+])\&
M>&5\/>']8^+EG/X-TCXB7&L^/+:U_P"$H_:"\;^&YI=<\4:[')I7A;P_;+(N
MLV6OZCJX!_#U^UCH7Q7T[]D_]KGXGP_%N^U3X1Z-_P '&7Q:\/:+^RII_@+P
MI%)K?QTM_AM\0/$.F?%NS^*[6NI^/X_+\,VG_"N#\.VM;WPM,VK6GB22Y&M6
MZQW?Z9)^VEH7QN\9?MV_#SQ_\!;S]@C]HSXYZMX)T+XW_P#!.TWGQ+^,/BO_
M (+">--1^*GQ@NY?@;I_BOQ1H)\=_LCW5I\0-5\?^![OQ;\#[_P_(?\ A<\U
MV)K$?#/2I[?ZZ_X)B_LY?L)Z;\9/^"A7_#TSXHZ7\+KSQ)_P49^/GB7X(?LJ
M?M<_$WP'\)O@YXS&N^*=._X1S]JKX5_"?XKVWA[7]<\?RRV_B'X<>%OC?X,U
M=T;PM<:QX;L99;V,W-K^:.L_#K_A2?\ P4?_ &N/ S_$;P+\8-+^'WQN^']I
MXF^-W[1?Q-TOQK_P5WTVVT?]I7X^:%KVN_\ !,*?[7H&J^-/VE+_ $[0+CQ!
MJVFZ#\._%,&F_$&_\&:Q;^'M#_MQH[D ]Q^(?_!(S_@G[XC_ .";?[2'[2W[
M47[&7CG_ ((L_&CX6ZSXDTOX8:9XR^,_QS^/EY\3[+3=,^%&H^%]6_X1CX@:
MO T<'BKQKXHO_A!#>V&C#3-$EUH^)]2:Z_L*7R_F7]D7XR^%?V?/V1_^".?C
M[]HGXPQ^'[SQ_P".OVWYOV5/VC]5\'2-'_P2L;PK\6[+0_BYXTD^&WA#2KK1
MOVNA\?\ 4-4TF_D\/_&W3T3X:QZ?#'X-4VNHRW%?KC\:="_X*,?MC^.)/V#O
MVS?AY8R?LOZO\#O&_P ;?AM\<O&O@7XP^'9K+4?".A_%3XH>&]!_:6^,/C[3
MKG1?".@-^T=^S5H6B>+= \5:#HFH7'[/OB/0X]"O8Y/&.A:Y;^3_ !FL/V.?
MBM^RE^QQI_Q&M?\ @GWXT_;/_9RN?VA?^%<^ OV./$O@'QI_P1C^&EY\3/B)
MH.LVU]^W3KWACQ%K]C\-_#/C+PU:6^J6E[XD\<^$#J'B[1=>OM_]FV2RD _-
MOP5KG_!'S0?^"EWAJ[^(W[3^A_'+6=?_ &B=)_;^\8_\%<)++XI?"^VM_B)I
M/CVW^*/BK]EW_AD;1+=_A[8Z9XT\5>%=6N)_B(MB=4T)?B/,-%T^+2O#^B:?
M'^JOQQ_X+K_M"_M%_M?ZU\$OV1/VB;']FK_@F7\&M T+0/B]_P % /#OP7\-
M?M ^&K7P!9^&M.T^_P#%^O\ A?X@?#4:CX<@U[Q_\2_AC\)+F&SU R:)>'3K
M])(KW5]1FB[J/_@E9_P2\_; 'P3\3_LS>*?^"<'C+]N7QC\)_AO\+?VK_P!F
MG]F_XU?!GQ/^S1X,\)ZYHX\-_M8_&[]GSX;>%?\ A*]=L?C=\--)\1:KXB^"
MGC74M?UNSTS7]'\(ZUXH\.^(,7\>J?7O@;X"?L.?#/\ 9T_;'_X)4?\ !.S]
MG3X)?$7]N3X%?#>*/XD1?MF_"O3-2^%GQ4M=1^('[/\ \3?&EW\4_B#X>T[P
MQ:>./#FAZ9\0?!EYX4M)K72(M,U3P-X4>ZT][7PFMW< 'Y6?LP?M/?M??LCV
MGQF\._$_X\>(OV(OV0OCU\?/'WQ9^&'_  6+\5?LQZ7\2_!_[2&C^+OB7\>_
MC%\-8M'^ >J>%-0\-:-#^U5X<^+;_&+PK=Z+=Z1+X,\.^")M,L['4+#5;QM,
M^+?A?\=_%W[5?_!9K]ES]A7]@C]K#_A47[%7[*FM_M$Z;_P3S^)OA_X/^%_B
M[-\*?!WB[]F7Q'XG^(HT_3_BMH%KXS^)MKXM?0?$7A.;4?C)KGBVY\-IJR7V
MC7-C?PZ29OV/_9'^-'[.WQ+\?VO[$_[;7Q5_8-\=?LM?!6TU'0/CI^SY^U5\
M5?A5IUQ\(OVIOA79ZKX0/@W]B/P1XS\6^'T\.?LW_!_XC2_'#X9?#'^U;!I-
M+_9AM/@=I>DZOJMOJ::EK'@_PY^#W['_ .QW\6OVV?V4/B_\#_&7[-.A?LK:
MM\*]!_X)[_M=?LO?";6_"'_!5+]H]?%U[J.K?'5/AU\2IM G?XZR>$_"6NC1
M?B3'\/OAE86?ACX%W.N7.JP'3;:'6X0#\VO$_P"WM_P51^+_ /P66_:'\0_L
M$?#O5?$W[2_PATWQS^SA\:?&'@OP/X-^(,GQ8^$_PM\7_ +X->,/B-KWA3Q-
MX;G\%?"NW\<^+/@1X(\6:J?#\$4'@:_\53^&K35/[-LY)KO_ $=_AE^T]\!_
MBQ\3/BC\'/AQ\2M)\9_$SX(KH5O\6_#MA::M#=>#=0\1:_XW\+:9!JTUSI5I
MI9O[_P 0?#7QK8SV.GW]U-82:!(UU;V=O>6$U]_"]=6G[*W_  3<^"_C1?VC
M[K_@H9^RG^T%\;?''CCQA\+?VU/@GX9U;PG\>?C)HWQ/U_XI_&?X9?"#]I7X
M]WGA=]'U;7?$_@KXE_"#7OC3\/Y=/T^]7XJ?"?4XM5N;>[^'-^)OZ%O^"&S:
M!X(?]H/X"?%JWA\0?M__  MTCX/77[7?Q2>T.L:A\0M5N3\0O!EC/J7Q*FCM
MM1^(NHP_&KX??M$>(KK5M2MY;F:?QBVOOJ-U/XGN4MP#^?'XM_\ !*;]J3_@
MHC_P4$^*WA;]NCXZ)\%_VA_"^N_$SX@?LB_#A8_AMX#_ .$B_8\T?XV-IWP]
M^)<NM? /]G7Q_P" +N\C\<>-$T*ZM?B?XUTWXVMNAN]?\,#18(=6?]#?V]_^
M"&O@;PCX:^&__!07QQ^T2?@_^TC^RW%KGQQ_:#_:HGNO[5MO%WBO3[WP5XQ3
MQKJ7P^T;]E_Q_H7C.XLOB):_$[Q++H7AGX.V"ZX_CU=(U'P_KFC2:/H'A[XW
M/_!1#_@J=\8_BQ^U1^T_H/Q>_P"".?[-_P /_P!G']J7XT?L(^$OC?\ MI:'
MI7PX^*VI?\(EXEG^(6G_  N\/_$272?%-[?66HZ)I.F^+IO#=OK6BQW_ (D\
M/ZGKD7AZ*73/M:V_BS^W1_P6Q^(7[)_[3_Q=M_VH/^"&W[;OP ^ GPY'B7]I
M'P9\,KK4/CYI\?AG58M2FL-)\1^";[PW!X5FC\;_ /"/ZO'H^A>,6TVRNCHE
M^UI%IL]G/* #[_\ V+/V\];\%_ +]J#X2?\ !5KXR>%_BW^U#XO\ _&?XD_L
MT:)J_@OPGX>\4?&+]D[1/@%XE.KZ)H6M_"WP5\)?"=A%/\6/AQ^TUX0LM(\3
M:IX$^(D^HV-ZT5VGA_Q#\/==U7\E/^"9G_!0_P#X-Q9/@S^U?\#OCO\  'P;
M^R-X-^+B>!=+U/0?$'A[]I;QP_Q1T>.R\6?:%TKQOI/QB_:9^('@R\\/7AC@
MU*Y\'>*?AQ<7-KX@TI(9=:N+*Z;0^9_X*D_L/?\ !1[_ (*/?&?]DCXW?LD_
M"F_\(6.E_L,?$G2/%?C[X*:+XL^%WPAM-8\-?&W]L^]U+X6>%;_P-IM_<CQA
MXT\&6,'A^?PMJ8:W\3>)OBKH^CBXBM/&&H&U_+/]A+_@WQ_;(\7^)]1^,/[8
M?['W[1?AO]G+X'7NE7GQ<^$.E>$?&7AS]IWXQZ7XDL_$L%G9?LR>$/\ A'?+
M^(>H^'-3MO#M_P"*D_X2'24T:SN[@O<3;VMH0#^@O]J#QU_P0W_X)/ZG^R;\
M9_\ @GYXDT[]GW]I?XG>+?V1/C#+KN@R?M3^/K'Q1^P3\=_&6C:G\4?$-UIG
MQ4B\<>#+:W\3?!FRO[^]TC6+.P^)UI;:=NBTR#7;@)>^O_M8_P#!0K]ASX/^
M*O W[07[,WC.U^$7BO\ X*>?#?PG_P )K_P4(T/PAXU\726<&J:GKWP_\=)+
MX*\;:?\ $F/PR\VJ?LE6G@@Z;X<_97\3:#97\%O?06-JVIZSKVGXWP+_ .".
MO[ W[>_PA^)7[1/[=_Q&DT[PG^R3+J_[/7PJT3X9_&9/!.O_ +*?[$O[+7P_
M\(I\/?A#^W1H>J:!>V_@7]L3X0>&KSQ1:?M.Z)J6IWEWH\M[92K(;9K>ZC_.
M;_@JY\-?AU\$?%?_  2\^'O_  2D^'OA#]M_P%X*\!6X_9Q^'FM>%+/]J_P)
M\6UE^(O[>WB'Q9#?^'+>Q_L[XDW/A[7;SQAJ=U:V\031-1\.33R0I'H4S( <
MG_P4>^ O_!*32OB%\"O#WB'Q=)\ _'_QW\%:%^T7\3?^"C7]O_M&PWGQUUKQ
ME\$OAE\3M>U:[\/^'-&\?:1X-@^,OBKXX0>,+S1?#O['WPJTG1]1L;'0+2#X
M=V-O%X9U?UK_ (*J?\%2_P!B3X@^'OVC?VF?V;?VY?"WQO\ VK?!'C3X7:G_
M ,$^-$NOV>_$VE7/[/VG>*Y+#X>_M+/JMQ\0?V3_ (=^$?'=WXT^$TVJ:0EK
M^T?XU^.%WI#03:EX!A\+^+[*ROX?Y<_^"@?[8G[37[6'Q970OVKO O@KX3>*
MO@9=:M\(I?A/\,/AG8_"6U^&%YX(TKP?\-+WX:WG@*TN+G_A&;?P5!\)-$\/
M6WA6Y@M3H<^AW%O;6<26TB6O]9O_  3P\6_\$H+3]D;_ ()<R^.K[_@A_"^F
M^!/C7<_\%&]*_;!\"?!'7?VG];\0ZC#K@^ L_AJ2Y\':U?7=[IWC&Z,_B^3Q
MEJ-KJ%MX-N/#\5F9;@7%O& >*^"OV:/^"AW_  79\*Z#H_B_]K[PK^T3\!/
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M#>Z)>6'B'P9XH^.'BKP+XAL=UU%?"R\1>$]9LUGL-.:"V@GT[3KFS /YI?\
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D%S?7D#:EJ,4*W=\EO=:GJ-S;PW,LD4%QJ%_/"J2WMRT@!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm222535d1_def14aimg002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm222535d1_def14aimg002.gif
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MC_>F: $#)"""R4U+&O*! 26G*((#6?32Y9=T:DPJP0$$DLF;FF3B YTQ VO
M#Z1\K)(6N7A2J,ZDSOP&L2OA<,>DZA:=@040E!!)(#<9X0@F)8RJ-7BG;M&+
MTA^UN@>L6L^* ".?X&K()SGT>G8&+/K_< HG-W&1RQT/&+IWLW[(DO FBE +
M]:46!) M*-QZ"T*XAR=PA,TWG9$+'UD7/6L&E+BYD@N77+*#IGL'ZT(OE/?[
M[P'*QEVP)Z\DO$@D+L!=-,1 O*+)35UHB_'CB'(,^TUPY()%Z#&?3$(FC-SD
MQ2>&F !SZPY8H<OP*XGQRA\YGTWP YP\NE(-H" R0YBM'TW*RBM](<HF(B"
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50,,50MI3BN3A$_,IZD=$9)2    [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm222535d1_def14aimg003.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm222535d1_def14aimg003.gif
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M P$" P$" P$" P$" P$" P$" PC_  ,(&$"@@(&#"!,J7,BPH4.$!0X,,(#
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-MMQVZZVVU29 1$  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm222535d1_def14aimg004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm222535d1_def14aimg004.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_X0Z717AI9@  34T *@    @ !P$2  ,
M   !  $   $:  4    !    8@$;  4    !    :@$H  ,    !  (   $Q
M  (    <    <@$R  (    4    CH=I  0    !    I    -  "OR    G
M$  *_(   "<0061O8F4@4&AO=&]S:&]P($-3,B!7:6YD;W=S #(P,3(Z,#0Z
M,C,@,3(Z-3(Z,C@      Z !  ,    !__\  * "  0    !    5Z #  0
M   !    4          & 0,  P    $ !@   1H !0    $   $> 1L !0
M  $   $F 2@  P    $  @   @$ !     $   $N @( !     $   UA
M     $@    !    2     '_V/_@ !!*1DE&  $"  !( $@  /_M  Q!9&]B
M95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 4 !7 P$B  (1 0,1 ?_=  0
M!O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MDDE/_]#U5)1)#1)T Y*YK,^O?3/6=A]#JMZ]G@?S.$-U32?HG(S3^KTU;O\
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MO_/-:2FC]</Z3]7?_3O3_P">LI)-]<?Z7]7/_3O5_P">LA))3__2O= ^L_\
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M24T#[0      $ !(     0 ! $@    !  $X0DE-!"8       X
M    /X   #A"24T$#0      !    !XX0DE-!!D       0    >.$))30/S
M       )           ! #A"24T$"@       0  .$))32<0       *  $
M         CA"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"A
MF9H !@       0 R     0!:    !@       0 U     0 M    !@
M 3A"24T#^       <   _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@     _____________________________P/H   X0DE-! @
M !     !   "0    D      .$))300>       $     #A"24T$&@     #
M60    8              %    !7    $@!N &4 =P!? &D ;@!P &4 <@!S
M &\ ;@!V &\ = !I &X 9P    $                          0
M        5P   %                       0
M   0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"
M=&]M;&]N9P   %      4F=H=&QO;F<   !7    !G-L:6-E<U9L3',    !
M3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M!V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I
M;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M    26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   !0
M %)G:'1L;VYG    5P    -U<FQ415A4     0       &YU;&Q415A4
M 0       $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .
M8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       )
M:&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=
M  EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.
M;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M      QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
M     #A"24T$*       #     $_\        #A"24T$$0       0$ .$))
M3004       $     3A"24T$#      -?0    $   !7    4    0@  %*
M   -80 8  '_V/_@ !!*1DE&  $"  !( $@  /_M  Q!9&]B95]#30 "_^X
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M;W7?GV?I/4]/T?\ 1KF__''^NW_EK9_F5_\ I-)3[!Z/^,7_ +E=(_[9R/\
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M "  4 !H &\ = !O ', : !O '     3 $$ 9 !O &( 90 @ %  : !O '0
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M68T4;DGH!BKSV^_-*75A/;?E_9)K\D/);C79Y/J^AVQ W9[P@_6N/>.Q2?\
MRY(L581=W'F&VTF/\UM.\XS>;Y-$N6.N:?8E8=(.F)R%[%9VP:AEMXW69;F:
M:5Y?07_4Q5[EI]]9ZA8V]_93+<6=W$D]M<1GDDD4BAD=3W5E(.*HC%78J[%7
M8J__T/5.*NQ5COGKS;+Y7T1=1BT]]0DEN;>SCC]1((4DNI5AC>XF>OHP>HZK
M)*L<O#E]C%7E/GGS#I5GJ8M/S)U!M:O5>SDE\IV >ST>TM[N811W5R\S(^I0
MQ7"K'-)*WH_O$_T"+%7G]SYG\U^;;*W-^%35?*T<>N:1Y:L!)9Z;>+I=TOZ2
MTVYM:R_Z;I[0_P"C+')R>W=)/2_>XJ]%_)9-1TK7[[2=(LK[5_RZUN&'4O+V
MH&2+]'6%E<B>:2U,4G%OK"W4CP2QHTLW#TVGBB]/XE65_EK(WE?7-1_+6X+F
MUL%;4O*LSEV]32II/BM^;EBSV$[>A]K_ 'G>WQ5Z1BKL5=BKL5?_T?5.*NQ5
M":IIEEJNF7>F7\0FLKZ&2WNH6Z/%*I1U/S4XJ\2\Z?ESJ/Y@>4[WRW+<B/\
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M17_5S\J?](E__P!5L5:^I?\ .1?_ %=/*G_2)?\ _5;%5GU+_G(__JZ^5/\
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4U.G+&H@]!U*-%Z8''@RDAEQ5_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
